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Gene therapy has emerged as a promising technique to treat many chronic diseases, 
genetic disorders and even cancer.  Furthermore, the recent discovery that RNA interference 
could be used as an approach to modulate protein expression in mammalian systems sparked a 
potential revolution in disease treatment.  By taking advantage of this endogenous mechanism, 
gene silencing can be induced by sequence-specific cleavage of a messenger RNA coding for a 
specific protein, by means of a short interfering RNA (siRNA).  Introducing siRNA into cells is 
limited by numerous challenges, predominantly the lack of effective delivery systems that can 
safely transport these macromolecules to their site of action while overcoming multiple barriers 
that hinder the delivery pathway.  For siRNA delivery, synthetic vectors, including polymers, 
have increasingly gained attention primarily due to their easily controllable molecular 
composition.    
In this work, we employed a combinatorial chemistry approach for the rational design of 
polymers as non-viral delivery systems.  We hypothesize that by developing libraries that 
correlate the structure-function relationship of polymeric vectors, optimal structural parameters 
will be identified for efficient transport and delivery of siRNA into cells.  Toward this goal, we 
carried out the controlled synthesis of poly(methacrylic acid) (pMAA) and poly(acrylic acid) 
(pAA) by reversible addition-fragmentation chain transfer (RAFT) polymerization.  Based on 
these two polymer precursors, we evaluated the conjugation of two ligands, D-(+)-galactosamine 
(Gal) and agmatine (Agm) to generate polymer libraries by varying the binary subtitution of both 
moieties.  Due to the higher Agm/Gal side chain substitution in pAA as compared to pMAA, 
pAA conjugates were selected for in vitro evaluation.  pAA was synthesized with four distinct 
molecular weights (Mn), specifically 3 kDa (PDI = 1.36), 5 kDa (PDI = 1.32), 10 kDa (PDI = 
1.19) and 21 kDa (PDI = 1.19).  For each polymer Mn, various combinations of Agm and Gal 
were substituted, for a total of 22 polymers under evaluation.   
From the biophysical and cellular characterization, it was determined that both the 
Agm/Gal content and the Mn significantly influence the ability of these polymer conjugates to 
serve as siRNA delivery systems.  As distinguished from these analyses, the higher the Agm 
content, the more compact and stable the polyplexes and the higher transfection efficiency, but 
also the higher cytotoxicity.  As for the effect of molecular weight, the lower the Mn, the more 
stable the polyplexes and the lower cytotoxicity, but also the lower transfection efficiency.   
Therefore, a critical balance between Agm/Gal content and polymer Mn must be attained to 
acheive favorable outcomes - these being high transfection efficiency with low cytotoxicity.  The 
best candidate identified was 5-P3, corresponding to a pAA Mn = 5 kDa, and Agm and Gal 
contents of 55% and 17%, respectively. 
The development of polymer libraries and their in vitro evaluation offered a better 
understanding of the structure-function relationship of polymeric vectors.  This approach 
provided the identification of optimal structural parameters and served as a synthetic foundation 
upon which safer and more efficient siRNA delivery systems can be developed.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 siRNA delivery 
For decades researchers have explored possibilities to treat or even cure chronic diseases, 
genetic disorders and cancer.  Recently, this search has encountered a potentially achievable 
route through nucleic acid delivery, a revolutionary therapeutic alternative.  Particularly, 
endogenous gene expression can be regulated through the RNA interference (RNAi) machinery 
within cells.  RNAi is an endogenous mechanism in which a short RNA post-transcriptionally 
interferes with the translation of a particular mRNA with a complementary nucleotide sequence.  
Silencing genes regulates endogenous cellular pathways and offers protection from invasion of 
nucleic acids by viral infections1,2.  RNAi was first identified in plants, and was shortly after 
recognized in fungi and animals, specifically the roundworm Caenorhabditis elegans.  In 1998, 
Fire and colleagues successfully suppressed protein expression in C. elegans by the insertion of a 
double-stranded RNA (dsRNA) that led to the degradation of homologous messenger RNA 
(mRNA)3.  Although RNAi is conserved in eukaryotic organisms, initial efforts to apply long 
dsRNA (> 30 base pairs) to mammalian cells resulted in a potent immune response by interferon 
release.  It was not until 2001 that Elbashir et al. reported suppression of protein expression by 
21-nucleotide short interfering RNA (siRNA) in mammalian cells, particularly, human 
embryonic kidney and HeLa cells4.  Ever since its discovery, siRNA has become a promising 
tool to investigate the function of targeted genes and has been contemplated for therapeutic use 
due to its high specificity and efficiency.  However, as a nucleic acid, siRNA suffers from low 
stability in serum due to nucleases and required assistance for efficient transport and delivery 
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into cells.  In addition, the high anionic density from the phosphate groups in the siRNA 
backbone and size prevents passive diffusion across cellular membranes.  Many of the siRNA 
delivery vehicles under investigation have been derived from previously studied DNA delivery 
vehicles and modified accordingly5.  However, there are many issues that must be taken into 
consideration for the design of non-viral siRNA delivery systems.  For years, researchers have 
developed different strategies to overcome the challenges encountered in siRNA delivery, many 
which are described hereafter.  
 
1.2 RNA interference 
 Several strategies can be executed to induce gene silencing in mammalian systems such 
as the delivery of synthetic siRNA, a 21-23 base pair nucleotide.  Other RNAi effectors include 
short hairpin RNA (shRNA), or plasmid DNA encoding for shRNA6.  Regardless of the 
approach, the molecular mechanism for interference is conserved.  After processing the RNAi 
effectors to achieve siRNA, the siRNA assembles with a multiprotein complex known as the 
RNA Induced Silencing Complex (RISC).  The siRNA is loaded into Argonaute protein (Ago2) 
within RISC which promotes cleavage of the sense strand generating a single-stranded RNA 
(antisense  or guide strand)7.  Although still unclear, it is believed that the selection of the sense 
strand is by thermodynamic asymmetry8.  The antisense strand guides the activated RISC to 
search and bind to a complementary mRNA sequence triggering its endonucleolytic cleavage by 
Ago2, and thus inhibiting protein expression (Figure 1.1).  RNAi-based therapies have become 
extremely attractive due to its high specificity toward a wide range of  mRNA targets. 
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Figure 1.1: RNA interference mechanism in mammalian cells (adapted from Doody, A. et al.6): 
1. shRNA is processed by Dicer to generate siRNA; 2. siRNA assembles  with a multiprotein 
complex, RISC; 3. RISC unwinds duplex siRNA, cleaves the sense strand, and uses the antisense 
strand to target mRNAs with complementary sequence; 4. RISC, guided by the antisense 
sequence siRNA, promotes cleavage and degradation of the mRNA. 
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1.3 Challenges of siRNA delivery 
The design of synthetic delivery vectors is extremely critical given that the system must 
surpass numerous extracellular and intracellular barriers confronted throughout the delivery 
pathway (Figure 1.2).  Among the extracellular barriers, the known challenges include siRNA 
packing (binding and encapsulation of siRNA), stability in plasma, nuclease resistance, 
avoidance of interactions with plasma proteins and uptake from non-target tissues, and increase 
in circulation time.   Once the target cell is reached, the delivery system must be effectively 
internalized by a specific pathway (i.e. receptor-mediated endocytosis), and promote cytosolic 
localization (endosomal escape while avoiding lysosomal encapsulation) and complex 
dissociation in the cytosol to allow the therapeutic effect.  More importantly, these vectors must 
provide minimal cytotoxicity to target and adjacent tissues as well as avoid potential immune 
responses. 
1.3.1 siRNA packing and stability. Naked siRNA can be locally administered to target tissues; 
however, for systemic delivery, rapid enzymatic degradation in the extracellular medium makes 
this alternative unfavorable.  Various chemical modifications and terminal modifications have 
been executed to increase siRNA stability and resistance to nucleases, such as cholesterol 
modifications and 2’-O-methyl modification9.   The molecular weight and average length of a 
21-23 base pair long siRNA is typically ~13 kDa and 6 nm, respectively.  Due to its size, renal 
clearance by glomerular filtration is likely for these molecules,  which is highly typical for 
globular protein of less than 40 kDa or nanoparticles with hydrodynamic diameter of 5-6 nm10.  
These hurdles encourage the use of delivery vectors to facilitate siRNA transport during systemic 
delivery.   
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Figure 1.2: siRNA delivery barriers (adapted from Wong, S. et al.11): (1) gene packing; (2) 
internalization; (3) escape from the endosome; (4) complex dissociation; (5) silencing protein 
expression. 
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 Several strategies have been implemented to encapsulate siRNA into a compact 
nanoparticle   to  protect  it  from  nuclease  activity.   The  most  common  approach  is  through 
electrostatic interactions with positively charged biomaterials.  Highly cationic biomaterials can 
produce a negative impact on the stability of the complex given that it can increase non-specific 
binding to proteins in plasma and to biological surfaces.  As a consequence, particle aggregation 
can be triggered leading to undesired side effects.  To avoid non-specific interaction of cationic 
complexes with proteins and increase systemic circulation, hydrophilic groups such as 
polyethylene glycol (PEG) are commonly incorporated into the design.  PEG can shield particles 
protecting them from aggregation and increase stability12,13. However, the degree of PEGylation 
can have a significant impact on cellular uptake14,15.  Alternatively, PEG can be directly 
conjugated to siRNA through cleavable disulfide bonds, a technique that has previously been 
shown to offer greater stability and resistance to enzymatic degradation than naked siRNA16. 
1.3.2 Cell targeting and internalization.  Systemic delivery of nanoparticles involves traveling 
through the bloodstream and penetration through the vascular endothelium wall to reach the 
target tissue.  Passive diffusion across the endothelial barrier is limited to nanoparticles with 
diameters of 5 nm or less.  Larger particles are more prone to accumulate in the liver, spleen and 
leaky tumors.  In the case of hepatocytes, fenestration of the liver endothelium is 100-150 nm.   
 There are several alternatives to target specific tissues.  Targeting ligands that are 
recognized by specific cell surface receptors can stimulate cellular internalization through 
clathrin-dependent or receptor-mediated endocytosis.  Particles with diameters of 200 nm or less 
are able to be internalized by cells through this pathway17.  Numerous functional groups 
including sugars16,18,19, antibodies20, peptides21,22 and folates23,24 are commonly incorporated into 
the synthetic delivery vectors depending on the target tissue.  For instance, galactose can interact 
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with asialoglycoprotein receptors in hepatocytes cell membrane13.   Galactose can also be used 
for targeting lung tissues through beta-galactoside-binding lectins in the cell surface25.  Similarly, 
mannose can be employed to target mannose receptors found in macrophages26.  Folate 
receptors, although found in healthy cells, are over-expressed in many cancer cells and can 
therefore be used for targeting. Other targeting ligands, including peptides and nucleic acid-
based aptamers, have been directly conjugated to siRNA27,28.  Moreover, innate cell-targeting 
mechanisms of viruses including cell penetrating peptides (CPP), such as Tat (transactivator of 
transcription) and integrin-binding RGD peptide, which allow rapid internalization into cells 
have been used29,30.  
1.3.3 Cytosolic localization.  For siRNA delivery, cytosolic localization is vital.  Following 
cellular internalization by receptor-mediated endocytosis, the delivery system will enter the 
endocytic pathway.  In this process, the endocytic vesicles will fuse with early endosomes, after 
which receptors can be recycled back to the plasma membrane.  Early endosomes will mature 
into late endosomes which will eventually fuse with lysosomes, the degradation organelle of the 
cell.  Lysosomes have lower pH (~5.0-5.5) values as compared to endosomes (~6.0).  It is 
imperative that the delivery system escapes from this pathway before reaching the lysosomal 
compartment to avoid degradation.  For this purpose, pH-responsive biomaterials that are able to 
destabilize the endosomal membrane by changes in pH within the compartments are very 
attractive15.  Other alternatives to induce endosomal escape is by the incorporation of 
endosomolytic reagents (i.e. chloroquine) that can destabilize the endosomal membrane or 
fusogenic peptides (i.e. HA2) that undergo conformational changes upon acidification of the 
endosome31. 
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1.4 Polymeric delivery systems 
1.4.1 Polycations.  Cationic  polymers  are  promising delivery  vectors  due  to  their  ability   to 
electrostatically interact with negatively charged phosphate groups along the siRNA backbone 
allowing complexation of the siRNA into nanometer-sized particles.  These interactions can 
protect the siRNA from enzymatic degradation and provide stability in the extracellular medium, 
as well as assist cellular uptake.  Cationic polymers including linear and dendrimeric poly-L-
lysine15,20,31, protamine22 and polyethyleneimine (PEI) have been evaluated for siRNA delivery.  
Among these, the most widely investigated polycation for nucleic acid delivery in vitro and in 
vivo is PEI, first introduced by Boussif and collaborators32.  PEI is considered one of the most 
effective delivery vectors due to its relatively high transfection efficiency and consistency in 
different types of cells.  In addition to forming a strong electrostatic interaction with negatively 
charged nucleic acids, the high density of amino groups in PEI are believed to offer buffering 
capacity below physiological pH.  It is hypothesized that this property triggers an increase in the 
osmotic pressure within the endosomal compartment inducing its rupture and allowing cargo 
escape into the cytosol (i.e the proton sponge effect).  The biophysical and structural 
characteristics of various PEIs with different architectures and molecular weights have been 
studied for siRNA delivery33.  However, despite its high transfection efficiency, PEI suffers from 
high cytotoxicity.  The cytotoxicity increases with increasing molecular weight and increasing 
branching34.  Various chemical modifications to PEI have been performed to address this 
disadvantage including structural modifications with lipids (i.e. stearic acid)20, PEG12,35,36, 
chitosan37 and poly(γ-benzyl-L-glutamate)38.  PEI has been used successfully for siRNA delivery 
in several tissues in vivo, such as lungs, nervous system and tumors13,16,20,39-41. 
1.4.2 Polysaccharides.  Polysaccharides are  an  attractive  alternative as  nucleic acid  delivery  
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vehicles due to their biocompatibility, biodegradability and reduced cytotoxicity.  Among these 
natural polymers, chitosan has been investigated for siRNA delivery42.  Reviews solely on 
chitosan-based delivery vectors are available43.  Other popular delivery systems are cyclodextrin-
based vectors.  Cyclodextrins are cyclic oligosaccharides composed of 6 to 8 D-(+)-glucose units.  
A successful cyclodextrin-based polycation was developed by Davis and collaborators44.  This 
delivery system, composed of cyclodextrin, PEG and transferrin, is able to encapsulate siRNA 
into small stable nanoparticles (~50 nm).  In cynomolgus monkeys, it showed high delivery 
efficiency with relatively mild immune responses at high doses (27 mg siRNA/kg) and is 
currently undergoing human clinical trials as the first targeted polymer-based delivery system.   
1.4.3 Dendrimers.  Dendrimers are highly branched, spherical structures with a core-shell 
arrangement attractive due to their ability for internal siRNA packing.  This internal packing is 
possible by incorporating positive charges to the interior structure while maintaining the surface 
charge neutral, for instance in polyamidoamines (PAMAM)45.  Other types of packing possible 
with dendrimers include surface adsorption and direct chemical conjugation.  Although 
dendrimers require a step-by-step synthesis approach, a high level of control over their molecular 
structure can be achieved.  Dendrimers may cause cytotoxicity due to apoptosis induction by 
mitochondria membrane permeabilization46.  The cytotoxicity is directly related to the molecular 
structure and surface charge47.  To avoid cytotoxicity and enhance biocompatibility, surface 
modifications, such as the incorporation of PEG, has been carried out48,49.  Other than PAMAM, 
poly(propylene imine) (PPI) has also been evaluated for siRNA delivery with promising 
outcomes for tumors in vivo49.  
1.4.4 siRNA-polymer conjugates.  siRNA can be chemically conjugated to small molecules, 
lipids, oligopeptides (i.e. CPPs) or polymers (i.e. PEG) to enhance stability and cellular uptake50.  
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The covalent attachment between the siRNA and the molecule or carrier is primarily through 
disulfide linkages, which are cleaved upon internalization into cells.  A particularly interesting 
delivery vehicle was developed by Rozema et al. named ‘siRNA Dynamic PolyConjugates’ for 
targeted delivery to hepatocytes51.  They incorporated various components, each with a specific 
purpose for enhanced intracellular delivery.  The system backbone is an amphipathic poly(vinyl 
ether) composed of butyl and amino vinyl ethers.  To this, PEG and N-acetylgalactosamine 
ligand, were reversibly attached through an acid-labile maleamate linkage, which can be cleaved 
within the endosome exposing the amines from the polymer backbone.  Finally, the siRNA was 
attached through a disulfide linkage.  This system was able to knockdown two different genes, 
apolipoprotein B and peroxisome proliferator-activator receptor alpha, in vivo up to 80-90% with 
no measurable cytotoxicity.      
1.4.5 Biodegradable polymers. Biodegradable copolymers have the advantage of integrating 
multiple desirable properties into one carrier.  For instance, poly(lactic-co-glycolic acid) (PLGA) 
is a biocompatible, biodegradable copolymer exploited for many pharmaceutical applications 
including drug/gene delivery.  For siRNA delivery, PLGA microspheres have been applied for 
sustained siRNA release in vivo52.  Additionally, surface modifications with cationic polymers 
such as chitosan or PEI have been carried out to improve cellular uptake53,54.  Other 
biodegradable copolymers that integrate various functionalities have been developed.  For 
instance, Convertine et al. produced a copolymer which incorporates a siRNA condensing block 
of dimethylaminoethyl methacrylate (DMAEMA) and a terpolymer endosomal-releasing block 
of DMAEMA, propylacrylic acid and butyl methacylate55. 
1.4.6 Combinatorial Libraries. Combinatorial chemistry approach is a appealing technique to 
investigate the structure-function relationship of synthetic vectors with nucleic acid delivery and 
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to develop new therapeutics56.  So far, combinatorial libraries have primarily focused on the 
development of DNA delivery vectors57-61.  However, design criteria borrowed from DNA-based 
vectors may not be optimal for siRNA delivery systems.  Thus, different approaches for siRNA-
based vectors need to be developed.  The most favorable structural characteristics of polymeric 
vectors for siRNA delivery can be efficiently investigated through this approach.  Mapping the 
structure-function parameter space through polymer libraries can help to understand the 
mechanisms of siRNA delivery leading to safer and more efficient delivery systems. 
 
1.5 Other relevant non-viral delivery systems 
 Other than cationic polymers, the leading non-viral vectors for siRNA delivery are 
cationic lipids.  Lipid-based delivery systems, such as liposomes, micelles and solid lipid 
nanoparticles (SLP), are attractive due to their biocompatibility and reduced cytotoxicity.  
However, poor complex stability ultimately affects their cellular uptake and delivery efficiency.  
Of particular interest, stable nucleic acid lipid particles (SNALPs) were recently developed and 
have been shown to be efficient for siRNA delivery in vivo, particularly for the liver62.  SNALPs 
are composed of ionizable cationic lipids coated with PEG.  Studies with cynomolgus monkeys 
showed that a single siRNA injection of this system produced a reduction in apolipoprotein B 
expression with a maximal silencing of 90%63.  Lipoloids, which are lipid-like materials, are also 
considered promising siRNA delivery vectors, showing high efficacy in vivo, specifically for the 
liver, at low doses (0.01 mg/kg)64.  The development of these lipoloids was achieved through 
combinatorial synthesis and screening of various types of materials which enabled the 
identification of optimal formulations for enhanced siRNA delivery65. 
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1.6 Clinical trials 
The  discovery of RNAi  sparked a  revolution in  the  search for potential new disease  treatment 
alternatives.  Ever since, the advancement in the development of RNAi-based therapies, 
particularly with siRNA, has been significantly increasing.  The first clinical trial was launched 
in 2004, for the treatment of age-related macular degeneration (Bevasiranib) by local siRNA 
delivery.  Afterwards, other siRNA-based therapies followed in clinical trials.  Although most of 
the siRNA therapeutics reaching this state are naked siRNA, delivery vectors including lipid-
based and cyclodextrin-based systems are also being evaluated.  siRNA-based treatments 
currently undergoing clinical trials are listed in Table 1.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
Table 1.1: Current clinical trials for siRNA-based treatments.a 
Company Product Vector 
Opko Health, Inc. Bevasiranib (macular degeneration – phase III) naked 
Sirna Therapeutics 
(Allergan) 
Sirna027 (Choroidal Neovascularization – 
phase II) 
chemically-
modified siRNA 
Alnylam Pharmaceuticals ALN-RSV01 (respiratory viral infection – 
phase II) 
lipid-based 
Nucleonics NUC B1000 (hepatitis – phase I) lipid-based 
Quark Pharmaceuticals 15NP (kidney injury – phase II) naked 
Pfizer/Quark 
Pharmaceuticals 
REDD14NP (macular degeneration – phase I) naked 
Calando Pharmaceuticals CALAA01 (Solid Tumors – phase I) cyclodextrin- 
polycations 
Pachyonychia Congenita 
Project 
TD101 (pachyonychia congenita - phase I) naked 
Silence Therapeutics AG Atu027 (solid tumors - phase I) lipid-based 
Tekmira Pharmaceuticals 
Corporation 
PRO-040201 (Hypercholesterolemia - phase I) liposome 
aInformation available through clinicaltrials.gov 
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CHAPTER 21 
RAFT POLYMERIZATION OF METHACRYLIC ACID AND ACRYLIC ACID 
 
2.1 Introduction 
Poly(methacrylic acid) (pMAA) and poly(acrylic acid) (pAA) are versatile polymers that 
can be employed in many processes.  One of the most attractive characteristics of these 
amphiphilic macromolecules is their unique responsiveness to pH and ionic strength.  These 
properties can be applied to many applications, including particle and micelle formation1-3 and 
hydrogel fabrication4,5.  
One of the major challenges in polymer synthesis is the control of molecular weight with 
narrow polydispersity indices (PDI), defined as the ratio of the weight average molecular weight 
(Mw) to the number average molecular weight (Mn).  Several techniques have been employed to 
synthesize methacrylic acid (MAA) and acrylic acid (AA) homopolymers and MAA- or AA-
containing block copolymers, including free radical polymerization (FRP)6 and atom transfer 
radical polymerization (ATRP)7.  FRP tends to produce uncontrolled polymerizations giving rise 
to high PDI values.  In the case of ATRP, direct polymerization of the acidic form is 
challenging8 and thus the salt form or other derivatives, such as sodium methacrylate9, n-butyl 
methacrylate10 and tert-butyl acrylate11 are typically used.   
 Reversible addition-fragmentation chain transfer (RAFT) polymerization, developed by 
Rizzardo and collaborators12, has risen to become a resourceful technique that can potentially 
address the limitations that other radical polymerizations encounter in MAA and AA 
polymerizations.  RAFT is a controlled/living free-radical polymerization method that uses both 
                                                 
1Reproduced in part with permission from Pelet, J.M., Putnam, D., Macromolecules 2009, 42, 1494-1499.  
Copyright © 2009 American Chemical Society. 
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a radical initiator (I) and a chain transfer agent (CTA).  The RAFT mechanism, shown in Figure 
2.1, involves a series of addition-fragmentation steps followed by chain equilibration between 
propagating radicals and dormant species, during which all polymer chains grow at equal rates.  
RAFT possesses many synthetic advantages, including applicability to a wide range of 
monomers, flexibility of reaction conditions (including water as the solvent) and the ability to 
produce complex architectures13.  The selection of the monomer-initiator pair and the 
polymerization conditions are critical factors that directly influence the outcome14,15.  RAFT 
polymerization of MAA and AA has been previously shown for block copolymers, such as 
poly(MAA-block-methyl methacrylate)13,16, poly(MAA-block-benzyl methacrylate)13, poly(N-
isopropylacrylamide)-block-pAA17 and poly(N-isopropylmethacrylamide)-block-pAA11.  
Additionally, RAFT homopolymerization of MAA has been reported by Yang, et al.18  They 
performed the synthesis and characterization, as well as a kinetics analysis, of MAA and N-
(isopropylacrylamide) homopolymers and poly(N-isopropylacrylamide)-block-pMAA block 
copolymers using the commercially available CTA, carboxylmethyl dithiobenzoate.  For MAA 
homopolymers, they reported a kinetic analysis based on a single set of reaction conditions 
(methanol, T = 60 ºC, [MAA]0 = 1.90 mol L-1 and [MAA]0:[I]0:[CTA]0 = 100:0.25:1) that 
generated MAA homopolymers with Mn up to 13,300 and PDI = 1.3.  However, carboxylmethyl 
dithiobenzoate degraded during the polymerization, which limits the polymerization control 
affecting particularly the PDI.  On the other hand, RAFT homopolymerization of AA has been 
reported previously using different CTAs and in a variety of solvents including ethanol, 2-
propanol, dioxane, methanol, water and dimethylformamide12,19-21.  Based upon these initial 
reports, we sought to identify a synthetic method to create relatively high Mn MAA and AA 
homopolymers with narrow PDI. 
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Figure 2.1: The RAFT mechanism.  Pn and Pm are polymer chains; Pn* and Pm* are propagating 
radicals; M is monomer;  I is radical initiator;  R and Z vary depending on the RAFT CTA.   
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 Herein we report the synthesis and characterization of pMAA and pAA by RAFT 
polymerization using 4-cyanopentanoic acid dithiobenzoate22 (CPA-DB) as the CTA under a 
range of synthesis conditions.  The system employs 4,4’-azobis(4-cyanopentanoic acid) (A-CPA) 
as a radical initiator, which in conjunction with CPA-DB, is an efficient RAFT initiator pair for 
several polymers including methacrylates12,23 and methacrylamides24,25.  In our analysis, we 
evaluated the effect of [MAA]0:[CTA]0 and[CTA]0:[I]0 ratios as well as two different solvents, 
methanol and water/1,4-dioxane, initial monomer concentration and pH on MAA 
homopolymerization in order to obtain well controlled polymerization that achieves relatively 
high Mn pMAA with narrow PDI.  Based on the results obtained for pMAA, pAA we synthesized 
in a similar fashion by RAFT polymerization in methanol.  We report the relationship of Mn with 
conversion as well as a kinetic analysis of both polymerization under various conditions.  In 
addition, we highlight the conditions that achieve a range of Mn with narrow PDI up to a Mn of 
113,900 with PDI~1.13 and Mn of 55,200 with PDI~1.23 for  MAA and AA 
homopolymerization, respectively. 
 
2.2 Materials and methods 
2.2.1 Materials. Methacrylic acid (99%), acrylic acid (99%), 4,4’-azobis(4-cyanopentanoic acid) 
(98.0%, Fluka) and 1,4-dioxane, anhydrous (99.8%) were purchased from Sigma-Aldrich and 
used as received.  Poly(methacrylic acid), sodium salt standards were purchased from 
Polysciences, Inc. (Warrington, PA) and Polymer Standard Services (Mainz, Germany).  
Elemental analysis was performed by Quantitative Technologies Inc. (Whitehouse, NJ).  Melting 
points were obtained using a Fisher-Johns melting point apparatus.  4-cyanopentanoic acid 
dithiobenzoate (CPA-DB) was synthesized as previously described by Mitsukami, et al.26 
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(Characterization: 1H NMR (300MHz, CDCl3, ppm): δ 1.95 (s, 3H), δ 2.40-2.78 (m, 4H), δ 7.40 
(m, 2H), δ 7.58 (t, 1H), δ 7.91 (d, 2H).  Elemental analysis: Calculated (C13H13NO2S2): C, 
55.89%; H, 4.69%; N, 5.01%.  Found: C, 56.15%; H 4.72%; N 4.86%.  Melting point: 97.0ºC).  
Unless otherwise stated, all other chemicals were purchased from Fisher Scientific at the highest 
purity available.   
2.2.2 RAFT polymerization.  Prior to every experiment, all liquid reagents were purged under 
argon or nitrogen for at least 10 min.  Individual stock solutions of the radical initiator (A-CPA) 
and CTA (CPA-DB) were prepared with the respective solvent to ensure accurate reactant ratios 
for a set of reactions at a given condition.  For the water/1,4-dioxane solvent (4:1 v/v) system, a 
water/HCl stock solution (pH = 4) was prepared.     
A representative example for MAA polymerization in methanol is as follows: in a 1mL 
glass ampule equipped with a magnetic stir bar, MAA (0.170 mL, 2 mmol) and CPA-DB (3.72 
mg, 13.3 µmol; in 0.5 mL of MeOH) were transferred using a fixed volume pipettor.  After 5 
min of purging under argon or nitrogen, A-CPA (0.93 mg, 3.3 µmol; in 0.170 mL of MeOH) was 
added to the ampule.  The solution was purged under argon or nitrogen for 2 additional min.  The 
ampule was flame-sealed and inserted in a 60 °C oil bath under continuous stirring.  The reaction 
was stopped at 24 h by inserting the ampule in an ice bath and exposing the solution to air.  The 
polymer was recovered by precipitation in a generous amount of stirring diethyl ether (~50 mL), 
filtered and dried under vacuum overnight. Mn and PDI calculated by GPC for this particular 
sample were 12,900 Da and 1.19, respectively and the percent conversion estimated by 
gravimetric analysis was 91%.  1H NMR (D2O, ppm): δ 1.07 (br s,3H), δ 1.98 (br s, 2H).   
A representative example for MAA polymerization in water/1,4-dioxane is as follows: to 
a 1 mL glass ampule with a magnetic stir bar containing MAA (0.170 mL, 2 mmol), water/HCl 
27 
 
(0.536 mL) at pH = 4 and CPA-DB (3.72 mg, 13.3 µmol; in 0.074 mL of 1,4-dioxane) were 
transferred using a fixed volume pipettor.  The solution was purged with argon or nitrogen for 5 
min followed by the addition of A-CPA (0.93 mg, 3.3 µmol; in 0.060 mL of 1,4-dioxane).  The 
ultimate pH of the solution was 2.8.  Following the addition of all reactants, the ampule was 
purged under argon or nitrogen for 2 additional min, flame-sealed and inserted in a 60 °C oil bath 
for 4 h under continuous stirring.  The product was purified with dialysis using Spectra/Por 
regenerated cellulose dialysis tubing (3.5 kDa MWCO) against deionized-water for 3 days and 
lyophilized for 24 h.  For the case of small molecular mass polymers (Mn < 7,000 Da), 
purification was performed using Spectra/Por regenerated cellulose dialysis tubing (1 kDa 
MWCO).  Mn and PDI calculated by GPC for this particular sample were 24,100 Da and 1.18, 
respectively and the percent conversion estimated by gravimetric analysis was 90%. 
A representative example for AA polymerization in methanol is as follows: in a 1 mL 
glass ampule equipped with a magnetic stir bar, AA (0.150 mL, 2.19 mmol) and CPA-DB (4.09 
mg, 14.6 µmol; in 0.4 mL of MeOH) were transferred using a fixed volume pipettor.  After 5 
min of purging under argon or nitrogen, A-CPA (1.02 mg, 3.65 µmol; in 0.180 mL of MeOH) 
was added to the ampule.  The solution was purged under argon or nitrogen for 2 additional min.  
The ampule was flame-sealed and inserted in a 60 °C oil bath under continuous stirring.  The 
reaction was stopped at 24 h by inserting the ampule in an ice bath and exposing the solution to 
air.  The polymer was purified and recovered by placing the solution under vacuum for 10 min to 
evaporate ~50% of the MeOH, diluting with deionized-water, dialyzing using Spectra/Por 
regenerated cellulose dialysis tubing (3.5 kDa or 1 kDa MWCO)  for 3 days against water and 
lyophilizing for 24 h.  Mn and PDI calculated by GPC for this particular sample were 7,400 Da 
and 1.21,  respectively and  the percent conversion estimated by  gravimetric analysis was  34%.     
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1H NMR (D2O, ppm): 1.8 (br t, 2H), δ 2.4 (br s,1H).  
2.2.3 Characterization of pMAA and pAA. Mn and PDI for pMAA and pAA were obtained 
using a Waters Gel Permeation Chromatography (GPC) system equipped with two 
UltrahydrogelTM columns (Waters) in series (500 Å and 250 Å), 1515 isocratic HPLC pump and 
2414 refractive index detector.  Temperature throughout the system was controlled at 30 °C.  The 
mobile phase employed was phosphate buffer saline (pH = 7.4) at a rate of 0.8 mL min-1 
calibrated with six individual poly(methacrylic acid), sodium salt standards with peak molecular 
weights ranging from 1,670 to 110,000 Daltons and PDI from 1.02 to 1.11.  1H NMR was 
performed using a Mercury 300MHz spectrometer with deuterium oxide (D2O) as the solvent 
and 3-(trimethylsilyl)-1-propanesulfonic acid, sodium salt (DSS) as an internal reference.  
Resonances were referenced to DSS at 0 ppm and HOD at 4.81 ppm. 
 
2.3 Results and discussion 
2.3.1 Effect of [monomer]0:[I]0:[CTA]0 ratios on MAA and AA polymerizations.  Both 
pMAA and pAA were synthesized via RAFT polymerization using A-CPA as the radical 
initiator and CPA-DB as the chain transfer agent (Figure 2.2).  For pMAA, two different 
[MAA]0:[CTA]0 ratios (150:1 and 250:1) as well as two [I]0:[CTA]0 ratios (0.25:1 and 0.1:1) 
were evaluated and compared.  The selection of reactant ratios is of vital importance for the 
polymerization control and directly impacts the final molecular weight.   
 Figure 2.3 shows the  relationship of Mn with conversion for pMAA under the selected 
reactant ratios in methanol at 60 °C. Experimental Mn as determined by GPC were compared 
with  theoretical Mn  calculated using  equation 2.127,  where [m]0  and  [RAFT]0   are  the initial 
monomer and CTA concentrations respectively,  x is the fractional monomer conversion,  Mo  is  
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Figure 2.2: Synthesis schematic of pAA or pMAA by RAFT polymerization 
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Figure 2.3: Relationship of Mn (GPC) and Mn (theory) with monomer conversion of MAA 
RAFT polymerization using A-CPA as the radical initiator and CPA-DB  as the chain transfer 
agent.  Three initial reactant ratios ([MAA]0:[I]0:[CTA]0) were selected: 150:0.25:1 (■), 
250:0.25:1 (▲) and  150:0.1:1 (●).  The polymerization was conducted in methanol at 60 °C 
with [MAA]0 = 2.4 mol L-1.  Mn (theory) was calculated using equation 2.1 for the three 
[MAA]0:[I]0:[CTA]0: 150:0.25:1 (∙∙∙∙∙), 250:0.25:1 (----) and 150:0.1:1 ().  Data points were 
generated from an average of two repetitions that had an error of less than 18%. 
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the molar mass of the monomer and MRAFT is the molar mass of the CTA. 
[ ]
[ ] RAFTMoRAFT
xoMom
thn,M +
⋅⋅
=     (2.1) 
 For all three conditions, Mn linearly increases with conversion, characteristic of 
controlled/living polymerizations.  The higher [MAA]0:[CTA]0 ratio yields higher Mn due to 
more free monomer available relative to the CTA initially present.  Maintaining [MAA]0:[CTA]0 
constant and lowering the [I]0:[CTA]0 ratio (from 0.25:1 to 0.1:1) has a small increasing effect 
on the Mn throughout the reaction.  This behavior has also been distinguished in methacrylamide-
based homopolymers employing the same CTA/I RAFT system24.   
It is usually desired to minimize the radical initiator species concentration (particularly 
[I]0 << [CTA]0) to favor polymer chain growth exclusively from the CTA species, which can 
give greater polymerization control and generate lower PDI14.  However, reducing the radical 
initiator concentration 2.5-fold did not have a significant impact on the PDI, which only at high 
conversions (> 88%) were under 1.20.  At low conversion, PDI has relatively high values and it 
gradually decreases as Mn increases (Figure 2.4A).  In particular, for [MAA]0:[I]0:[CTA]0 = 
150:0.25:1 in methanol, PDI decreased from 1.52 at 8% conversion to 1.19 at 91% conversion.  
Similar continuously decreasing behavior was observed for all other conditions analyzed.  For 
[MAA]0:[I]0:[CTA]0 = 250:0.25:1, a PDI of 1.17 was achieved at 80% conversion and for  
[MAA]0:[I]0:[CTA]0 = 150:0.1:1, a PDI of 1.20 was achieved at 88% conversion.  It is important 
to note that changes in the solution color were not observed even at long reaction times, 
suggesting that the CTA remained undegraded throughout the reaction.   
Experimental Mn for the lower reactant ratios ([MAA]0:[CTA]0 = 150:1) were very 
consistent with theoretical Mn calculated based on actual monomer conversion data demostrating 
a controlled polymerization behavior.  Higher reactant ratios ([MAA]0:[CTA]0 = 250:1) 
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experienced slightly higher experimental Mn than theoretical Mn (~1.3 times higher) relative to 
lower reactant ratios.  Still, high reactant ratios maintained good agreement with theoretical 
values.  For the current system, the effectiveness of the chosen chain transfer agent with a good 
free-radical leaving group was demonstrated by the controlled polymerizations achieved that 
generated polymers with narrow PDI and Mn consistent with theoretical values. 
Given the controlled polymerization of MAA in methanol, AA was polymerized in a 
similar fashion with [AA]0:[I]0:[CTA]0 = 150:0.25:1 and [AA]0 = 3.0 mol L-1.  Figure 2.4B 
shows the  relationship of Mn and PDI with conversion at these conditions.  Although relatively 
higher experimental Mn were obtained compared to theoretical values, a linear trend of Mn with 
conversion was achieved, characteristic of controlled/living polymerizations.  Similarly to MAA, 
PDI gradually decreases as Mn increases.  Particularly, PDI decreased from 1.36 at 4% 
conversion to 1.24 at 79% conversion.      
2.3.2 Effect of solvent selection on MAA and AA polymerizations.  Solvent selection has a 
dramatic effect on the Mn profiles as well as on the polymerization kinetics.  A variety of 
solvents, including different organics (i.e. benzene, dimethylformamide, ethyl acetate and 
methanol) in addition to water-based solvent systems have been employed in many RAFT 
polymerization13,15,18,28.  The potential applicability of water-based solvents to RAFT 
polymerizations offers many advantages mainly due to their stability, low cost and ease of use.  
In particular, pMAA has higher solubility in alcohols and water than in most organics and its 
previous synthesis was performed in methanol18.  Therefore, we investigated the effect of solvent 
on the polymerization progression by comparing an alcohol (methanol) with an aqueous system 
(water/1,4-dioxane) while  maintaining all other  parameters constant  (i.e. temperature, reactant 
ratios and concentration).  Because CPA-DB is not readily soluble in water at room temperature,                                                                                         
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Figure 2.4:  Relationship of Mn (GPC), Mn (theory) and PDI with conversion of MAA (A) and 
AA (B) RAFT polymerizations using A-CPA as the radical initiator and CPA-DB as the chain 
transfer agent.  Mn (theory) was calculated using equation 2.1.  The polymerization was 
conducted at [monomer]0:[I]0:[CTA]0 = 150:0.25:1 in methanol at  60 °C with [MAA]0 = 2.4 mol 
L-1 and [AA]0 = 3.0 mol L-1.  Data points were generated from an average of two repetitions that 
had an error of less than 13%.    
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the addition of a water-miscible organic solvent, in this case 1,4-dioxane, was used  to further 
enhance solubility.  The co-solvent  issue could have been avoided by selecting a CTA with 
higher water solubility (i.e. trithiocarbonate). 
As seen in Figure 2.5 for the water/1,4-dioxane solvent system, Mn increases linearly with 
conversion obtaining much higher values (~2 times higher) than both the theoretical Mn 
calculated using equation 2.1 and the methanol system under the same reaction conditions.  A 
remarkable increase in viscosity after 4 h (90% conversion) which increased until 30 h (93% 
conversion) in addition to a change in color after 30 h was observed.  Interestingly, like 
methanol, the water-based solvent system achieved low PDI values at high conversion (PDI < 
1.20 at conversions > 85%).  The apparent rapid increase in Mn could be attributed to many 
factors such as a faster reaction rate due to higher propagation rate coefficient in this particular 
solvent system.   However, the deviation from theoretical Mn and change in solution color 
indicates poorer stability of the reactants in aqueous solutions than in methanol, suggesting that 
the latter is a better solvent choice to achieve greater polymerization control.   
One of the undesirable effects associated with water-based systems is the potential 
hydrolysis of the dithioester group of the CTA, which is temperature and pH dependent28,29.  
CTA hydrolysis leads to its inactivation, generating fewer reactive species than originally 
introduced into the system leading to higher Mn than the initialy calculated.  Therefore, the pH of 
the solution was maintained at ~3, since for this particular CTA, low pH values have shown to 
reduce the hydrolysis rate of the dithioester group29,30.  
To further investigate the behavior of MAA RAFT polymerization in water-based 
solvent, several experiments were performed in different pH solutions.  Table 2.1 shows the data 
for aqueous MAA RAFT polymerization conducted at different pH ranging from 2.8 to 12.8.  At 
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Figure 2.5: Relationship of Mn (GPC), Mn (theory) and PDI with monomer conversion of MAA 
RAFT polymerization using A-CPA as the radical initiator and CPA-DB as the chain transfer 
agent in two different solvent: methanol (■) and  water/1,4-dioxane (4:1 v/v) (♦).  Dotted line 
(····) represents Mn (theory) of MAA RAFT polymerization in methanol and solid line () 
represents Mn (theory) of MAA RAFT polymerization in water/1,4-dioxane, both calculated 
using equation 2.1.  The polymerizations were conducted at [MAA]0:[I]0:[CTA]0 = 150:0.25:1 at  
60 °C with [MAA]0 = 2.4 mol L-1.  Data points were generated from an average of two 
repetitions that had an error of less than 16%. 
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constant reaction time (t = 4 h), the monomer conversion gradually decreases as the solution pH 
increases.  The same behavior applies to Mn with the exception of pH = 12.8, where the bimodal 
molecular weight distribution shifted Mn to a higher value (Figure 2.6).  PDI progressively 
increases as the solution becomes more basic achieving PDI~2 at pH of 12.8.  Under this 
condition (pH 12.8), the loss of polymerization control was clearly observed due to the large 
disagreement with theoretical Mn, high PDI, pronounced solution decoloration and formation of a 
bimodal molecular weight distribution, consistent with findings of Albertin et al.31 using the 
same CTA agent in basic pH solutions.  This behavior has been attributed to degradation of the 
CPA-DB due to hydrolytic instability in basic pH solutions. 
 For pAA, polymerizations in three additional solvents, ethanol, 2-propanol and water/1,4-
dioxane (4:1 v/v), were conducted at analogous conditions to polymerizations conducted in 
methanol for 48 h.  Data for these polymerizations are included in Table 2.2.  Polymerizations 
conducted in alcohols yielded similar Mn and monomer conversions.  Polymerization conducted 
in water/1,4-dioxane yielded higher experimental Mn (2.2-fold) and higher monomer conversions 
(1.4-fold); however, PDI remain comparable to the PDI obained for reactions in methanol.  This 
behavior in water-based solvent systems is in accordance with the previous results obtained for 
MAA RAFT polymerizations in water/1,4-dioxane.    
 2.3.3 Kinetic analyses of MAA and AA polymerization.  MAA and AA homopolymerizations 
are characteristic of pseudo-first order kinetics that takes place after an initial apparent induction 
period which is a stage of slow reaction rate dependent on many factors including the 
monomer/CTA selection.  The induction times for MAA polymerizations were estimated to be 
short (< 1.5 h) for all cases.  In the case of AA polymerizations, the induction time was relatively 
longer (~5.7 h).   As seen in  Figure 2.7A  for MAA, the polymerization  develops  linearly with   
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Table 2.1: Experimental and theoretical Mn, PDI and monomer conversion data for aqueous 
MAA RAFT polymerizations conducted at different pH.a 
 
Entry pH Mn (GPC)b PDIb Conversionc (%) Mn (theory)d 
1 2.8e 24,100 1.18 90 11,900 
2 4.8f 10,700 1.39 54 7,300 
3 6.7f 5,000 1.41 25 3,500 
4 12.8f 8,600 1.95 12 1,800 
 
aMAA RAFT polymerizations were conducted in water/1,4-dioxane (4:1 v/v) at 60 °C for 4 h using A-CPA as 
radical initiator and CPA-DB as chain transfer agent with [MAA]0:[I]0:[CTA]0 = 150:0.25:1 and [MAA]0 = 2.4 mol 
L-1.  Data was generated from an average of two repetitions that had an error of less than 5%.   bAs determined by 
gel permeation chromatography calibrated with poly(methacrylic acid) standards with PBS (pH=7.4) as mobile 
phase.  cAs determined by gravimetric analysis. dAs determined using equation 2.1.  epH of solution was adjusted by 
HCl additions.  fpH of solution was adjusted by NaOH additions.   
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Figure 2.6: Molecular weight distributions for MAA RAFT polymerizations using A-CPA as the 
radical initiator and CPA-DB as the chain transfer agent, conducted at 60 °C with 
[MAA]0:[I]0:[CTA]0 = 150:0.25:1 and [MAA]0 = 2.4 mol L-1.  Polymerizations were carried out 
in water/1,4-dioxane (4:1 v/v) at different pH. 
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Table 2.2: Experimental and theoretical Mn, PDI and monomer conversion data for aqueous AA 
RAFT polymerizations conducted in different solvents.a  
 
 
aAA RAFT polymerizations were conducted at 60 °C for 48 h using A-CPA as radical initiator and CPA-DB as 
chain transfer agent with [AA]0:[I]0:[CTA]0 = 150:0.25:1 and [AA]0 = 3.0 mol L-1.  Data was generated from an 
average of two repetitions that had an error of less than 6%.   bAs determined by gel permeation chromatography 
calibrated with poly(methacrylic acid) standards with PBS (pH = 7.4) as mobile phase.  cAs determined by 
gravimetric analysis. dAs determined using equation 2.1. 
 
 
 
 
 
 
 
 
 
 
Entry Solvent Mn (GPC)b PDIb Conversionc (%) Mn (theory)d 
1 methanol 13,800 1.23 57 8,400 
2 ethanol 13,700 1.22 63 9,200 
3 2-propanol 11,200 1.32 57 8,400 
4 water/1,4-dioxane 30,000 1.21 82 11,800 
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time until nearly complete monomer consumption where the rate of polymerization is minimal 
and cannot be accurately measured.  Increasing [MAA]0:[CTA]0 causes a decrease in the 
polymerization rate; however, PDI is not affected and the ultimate Mn obtained is higher.  
Moreover, reducing the concentration of radical initator decreases the polymerization rate due to 
the lack of radical initiator species that could potentially initiate polymer chains.  In agreement 
with Figure 2.5, the solvent has a dramatic effect on polymerization rate.  For the aqueous 
system the polymerization progresses extremely rapid at very short times and slows after about 6 
h, a behavior that might have been affected by the type of solvent and increase in viscosity.  AA 
polymerization evolves much slower than MAA polymerization in methanol (Figure 2.7B).  This 
slow polymerization rate will influence the reaction time required to achieve complete monomer 
conversion and can also ultimately affect the PDI.     
 Several factors, including initial monomer concentration and temperature, have been 
found to directly impact the propagation rate coefficients in free-radical polymerizations of 
MAA32-35.  For this reason, we investigated the effect of initial monomer concentration on MAA 
RAFT polymerizations in both solvents.  
Table 2.3 includes the data for MAA homopolymerizations at three initial MAA 
concentrations, 1.0 mol L-1, 2.4 mol L-1 and 5.0 mol L-1 in two solvents, methanol and water/1,4-
dioxane, at 60 °C.  For both systems (aqueous and methanol), it is apparent that at the same 
reaction time, higher [MAA]0 yields higher monomer conversion which may indicate that the 
polymerization becomes faster as [MAA]0 increases.  For the aqueous systems at high monomer 
conversions, all three conditions demonstrated similar high deviation from theoretical Mn values 
calculated using equation 2.1.  However, higher [MAA]0 generated polymers with narower PDI.  
For the methanol system, all three conditions achieve narrow PDI at high monomer conversion.     
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Figure 2.7: Relationship of ln([M]0/[M]) with time.  (A) MAA RAFT polymerization at three 
initial reactant ratios and two different solvents.  Ratio (MAA:I:CTA), solvent → ■ 150:0.25:1, 
methanol; ▲ 250:0.25:1, methanol; ● 150:0.1:1, methanol; ♦ 150:0.25:1, water/dioxane (4:1 
v/v).  The polymerizations were conducted at  60 °C with [MAA]0 = 2.4 mol L-1.  Solid lines 
() represent linear regressions calculated based on short times only where chain growth is 
linear with time (16 h for methanol and 2 h for water/1,4-dioxane).  R2 values for linear 
regressions > 0.97 for all cases.  (B) AA RAFT polymerization.  Ratio (AA:I:CTA), solvent → 
► 150:0.25:1, methanol.  The polymerizations were conducted at  60 °C with [AA]0 = 3.0 mol 
L-1.  Solid lines () represent linear regressions.  R2 values for linear regressions > 0.99.  Data 
for MAA RAFT polymerization at analogous conditions ([MAA]0:[I]0:[CTA]0 = 150:0.25:1, 
methanol) was included for comparison (■). 
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Table 2.3: Experimental and theoretical Mn, PDI and monomer conversion data of MAA RAFT 
polymerization conducted at different initial MAA concentration in two solvents, methanol and 
water/1,4-dioxane (4:1 v/v).a 
Entry Solvent [MAA]o (mol L-1) 
Time 
(hrs) 
Mn 
(GPC)b PDI
b Conversion (%)c 
Mn 
(theory)d 
1 water/1,4-dioxane 1.0 0.5 4,200 1.34 21 3,000 
2 water/1,4-dioxane 1.0 2 17,600 1.38 82 10,900 
3 water/1,4-dioxane 2.4 0.5 5,500 1.36 25 3,500 
4 water/1,4-dioxane 2.4 2 21,600 1.17 84 11,100 
5 water/1,4-dioxane 5.0 0.5 3,400 1.65 31 4,300 
6 water/1,4-dioxane 5.0 2 22,200 1.18 91 12,000 
7 methanol 1.0 4 2,000 1.32 5 900 
8 methanol 1.0 24 10,800 1.17 60 8,000 
9 methanol 2.4 4 3,400 1.48 25 3,500 
10 methanol 2.4 24 12,900 1.19 91 12,000 
11 methanol 5.0 4 6,900 1.28 40 5,400 
12 methanol 5.0 24 19,600 1.11 89 11,800 
 
aMAA RAFT polymerizations were conducted in methanol or water/1,4-dioxane (4:1 v/v) at 60 °C using A-CPA as 
radical initiator and CPA-DB as chain transfer agent with  [MAA]0:[I]0:[CTA]0 = 150:0.25:1.  Data was generated 
from an average of two repetitions that had an error of less than 17%.  bAs determined by gel permeation 
chromatography calibrated with poly(methacrylic acid) standards with PBS (pH = 7.4) as mobile phase.  cAs 
determined by gravimetric analysis. dAs determined using equation 2.1.   
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Still, higher [MAA]0 seems to have a greater deviation from theoretical values suggesting that 
lower [MAA]0 in methanol acheives better polymerization control.  
2.3.4 Effect of increasing [monomer]0:[CTA]0 ratio on molecular weight.  Table 2.4 includes 
experimental Mn determined by GPC, theoretical Mn calculated using equation 2.1, monomer 
conversions and PDI values for the range of investigated [MAA]0:[CTA]0 ratios of RAFT 
polymerizations performed in methanol at an initial monomer concentration of 2.4 mol L-1 and 
constant reaction time of 48 h.  By adjusting the [MAA]0:[CTA]0 ratio, a variety of Mn were 
obtained ranging from 4,600 up to 113,900.  In agreement with the controlled behavior of RAFT 
polymerizations, when Mn is normalized with conversion and plotted against [MAA]0:[CTA]0 
ratios, a linear trend (Figure 2.8A) is observed as expected, consistent with theoretical Mn values.  
Excluding very low [MAA]0:[I]0:[CTA]0 ratios (50:0.25:1 and 100:0.25:1), all PDI obtained by 
GPC were below 1.20.   
For the RAFT polymerizations of AA, Table 2.5 includes experimental Mn determined by 
GPC, theoretical Mn calculated using equation 2.1, monomer conversions and PDI values for the 
range of investigated [AA]0:[CTA]0 ratios of RAFT polymerizations performed in methanol at an 
initial monomer concentration of 3.0 mol L-1 and constant reaction time of 48 h.  Similar to 
MAA polymerizations, by adjusting the [AA]0:[CTA]0 ratio, a variety of Mn were obtained, 
ranging from 2,900 up to 55,100.  Due to the lower polymerization rate, at a fixed reaction time 
of 48 h, the monomer conversion were much lower (37% - 67%) than for MAA polymerizations.  
This is accompanied by slightly higher PDI obtained for AA polymerizations.  Nevertheless, a 
linear trend results for Mn normalized with conversion plotted against [AA]0:[CTA]0 ratios 
(Figure 2.8B), characteristic of controlled polymerizations.        
Though a specific Mn can be obtained by  allowing the  polymerization to progress until a 
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Table 2.4: Experimental and theoretical Mn, PDI and monomer conversion data of MAA RAFT 
polymerization conducted in methanol at different initial reactant ratios ([MAA]0:[CTA]0).a  
Entry [MAA]0:[CTA]0 Mn (GPC)b PDIb Conversion (%)c Mn (theory)d 
1 50 4,600 1.36 97 4,500 
2 100 8,100 1.24 96 8,500 
3 150 16,700 1.18 89 11,800 
4 225 21,900 1.15 86 16,900 
5 375 35,600 1.15 88 28,700 
6 500 42,200 1.15 86 35,300 
7 750 56,200 1.15 80 51,900 
8 1250 82,300 1.16 77 83,100 
9 2500 113,900 1.13 49 105,700 
 
aMAA RAFT polymerizations were conducted in methanol at 60° C for 48 h using A-CPA as radical initiator and 
CPA-DB as chain transfer agent with [I]0:[CTA]0 = 0.25:1 and [MAA]0 = 2.4 mol L-1.  Data was generated from an 
average of three repetitions that had an error of less than 7%.  bAs determined by gel permeation chromatography 
calibrated with poly(methacrylic acid) standards with PBS (pH = 7.4) as mobile phase. cAs determined by 
gravimetric analysis. dAs determined using equation 2.1.   
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Table 2.5: Experimental and theoretical Mn, PDI and monomer conversion data of AA RAFT 
polymerization conducted in methanol at different initial reactant ratios ([AA]0:[CTA]0).a  
Entry [AA]0:[CTA]0 Mn (GPC)b PDIb Conversion (%)c Mn (theory)d 
1 50 2 900 1.36 37 2 000 
2 80 5 700 1.31 53 4 200 
4 110 7 300 1.24 42 4 600 
5 150 13 000 1.22 53 7 700 
6 275 20 900 1.19 53 13 900 
7 350 33 200 1.21 65 21 700 
8 620 55 100 1.23 67 39 300 
 
aAA RAFT polymerizations were conducted in methanol at 60 °C for 48 h using A-CPA as radical initiator and 
CPA-DB as chain transfer agent with [I]0:[CTA]0 = 0.25:1 and [AA]0 = 3.0 mol L-1.  Data was generated from an 
average of three repetitions that had an error of less than 7%.  bAs determined by gel permeation chromatography 
calibrated with poly(methacrylic acid) standards with PBS (pH = 7.4) as mobile phase. cAs determined by 
gravimetric analysis. dAs determined using equation 2.1.   
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Figure 2.8: Relationship of Mn/conversion (GPC), Mn (theory) and PDI with initial reactant ratio 
([monomer]0:[CTA]0) using A-CPA as the radical initiator and CPA-DB as the chain transfer 
agent.  The polymerizations were conducted at 60 °C for 48 h.  (A) MAA RAFT polymerization.  
For each reaction, the solvent volumes were adjusted to maintain the MAA concentration at 2.4 
mol L-1 (0.21 g/mL).  Data points were generated from an average of three repetitions that had an 
error of less than 7%.  Error bars represents standard errors.  (B) AA RAFT polymerization.  For 
each reaction, the solvent volumes were adjusted to maintain the AA concentration at 3.0 mol L-1 
(0.28 g/mL).  Data points were generated from an average of two repetitions that had an error of 
less than 5%.   
 
 
 
 
 
47 
 
specific monomer conversion (or a definite time), varying the [monomer]0:[CTA]0 ratio and 
allowing the polymerization to continue to near completion seems to be a more effective 
approach given that it can yield polymers with narrower PDI.  In this case, we fixed the reaction 
time to have a controlled variable.  However, higher [monomer]0:[CTA]0 required longer times 
to reach completion which is why a normalized Mn was included in the plot for molecular 
weights vs. reactant ratios shown in Figure 2.8(A-B).  For high reactant ratios in MAA 
polymerizations (2500:0.25:1), Mn was as high as 113,900 at only 49% conversion with a narrow 
PDI of 1.13.  For AA polymerizations, Mn up to 55,100 with 67% conversion and PDI of 1.23 
were achieved.  Narrow PDIs for low Mn polymers using this system are difficult to achieve but 
could be obtained by employing a CTA with much higher transfer constant.  Experimental Mn 
obtained were slightly higher than the theoretical values calculated from conversion data since 
the theoretical values assume absolute polymerization control and non-degradation of the CTA 
which, although to a minimal extent, is inevitable even in alcohol systems. 
 
2.4 Conclusions 
 RAFT polymerization was employed to synthesize pMAA and pAA with controlled 
molecular weights and narrow PDIs.  Both polymers can potentially serve as precursors to 
polymer conjugates; therefore, they were further evaluated for single and binary conjugations of 
two ligands, D-(+)-galactosamine and agmatine.  However, only pAA was selected as a precursor 
to polymer conjugates to be evaluated for siRNA delivery due to a higher degree of conjugation 
for both ligands as compared to pMAA.  For the polymer libraries evaluated, pAA with four 
distinct Mn, 2,900 (PDI = 1.36), 4,800 (PDI = 1.32), 10,400 (PDI = 1.19) and 20,900 (PDI = 
1.19), were synthesized as herein described.   
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CHAPTER 31 
AN IN-DEPTH ANALYSIS OF POLYMER ANALOGOUS CONJUGATION USING 
DMTMM  
 
3.1 Introduction 
 Combinatorial libraries have become increasingly prominent in the field of functional 
biomaterials.  For instance, combinatorial libraries of polymers1 have been widely explored for 
biomedical applications including gene delivery2-8 and medical device development9-11.  Of 
particular importance to the advancement of the field is the development of new synthetic 
strategies to create increasingly larger and more diverse libraries.  In particular, polymeric 
libraries provide insight to the structure-function relationships of biomaterials to identify 
favorable structural parameters and allow further optimization of their design. 
 One approach for creating diverse polymer libraries is polymer-analogous conjugation of 
functional groups to polymer scaffolds.  For example, coupling between the carboxyl groups of a 
polymer and the amino groups or hydroxyl groups of different ligands can lead to polymer 
libraries with a range of pre-engineered functionalities.  Over the past few years, numerous 
condensing agents have been developed and extensively used to form amides and esters12,13.  
Carbodiimides, such as dicyclohexylcarbodiimide (DCC) and N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide (EDC), are particularly popular condensing agents.  While these condensing 
agents are widely used, their synthetic byproducts can be difficult to remove.  Additionally, 
many of these reagents require the use of organic solvents and anhydrous conditions to avoid 
competitive hydrolysis by water, and are expensive.  Condensation of both 
                                                 
1Reproduced in part with permission from Pelet, J.M., Putnam, D., Bioconjugate Chem. 2011, DOI: 
10.1021/bc100125r.  Copyright © 2009 American Chemical Society. 
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poly(methacrylic acid) (pMAA) and poly(acrylic acid) (pAA) with amine-containing antibodies 
has been previously reported with carbodiimides and N-hydroxysuccinimide (NHS)14.  [1,3,5]-
triazine based condensing agents have been exploited due to their great versatility15,16.  Recently, 
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) was developed 
and shown to facilitate an efficient one-step condensation of both small molecules and 
polymers17-19.  Other favorable attributes of DMTMM are easy removal of excess reagent and 
byproducts from the reaction, compatibility with many solvents including water, alcohols and 
diethyl ether, ethyl acetate and tetrahydrofuran16, high reaction yields, and it is relatively 
inexpensive.  DMTMM can adapt to a wide pH range, and in some cases no rigorous pH control 
is necessary20,21.  DMTMM has been employed for the modification of a number of polymers 
including polysaccharides21,22, poly-γ-D-glutamic acid23, and as a coupling agent for 
peptidomimetics24.   Furthermore, DMTMM has been previously reported for direct conjugation 
of amine-containing ligands, including hydrophobic and hydrophilic groups, to pAA20.  Although 
these groups were substituted to the side chains with high efficiency, successful conjugation is 
dependent on a manifold of parameters including the ligand properties, particularly when 
cationic species are involved.  To our knowledge, the optimization for effective conjugation of 
such moieties to polymer precursors using DMTMM has yet to be reported.  The characterization 
of post-polymerization modifications of polymers with structurally heterogeneous functional 
groups will be of significant benefit for the development of new materials. 
 Herein we report the conditions for optimal polymer-analogous conjugation of two 
diverse model ligands, D-(+)-galactosamine (Gal) and agmatine (Agm), to the side chain 
carboxyl groups of both pMAA and pAA.  The choice of these two amine-containing ligands is 
based on their unique structural characteristics, particularly their different size and net charge, 
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which can influence the conjugation efficacy by steric hindrance or electrostatic effects.  We 
report optimal conditions under which these model ligands conjugate to pMAA and pAA using 
DMTMM and create limited polymer libraries containing several single and binary substitution 
ratios of both ligands to each individual polymer.  The goal of this work is to form the synthetic 
foundation upon which large, diverse polymer libraries can be generated to investigate the 
structure-function relationships of polymeric materials.  
 
3.2 Materials and Methods 
3.2.1 Materials.  4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride hydrate 
(+99%) and D-(+)-galactosamine hydrochloride (99%) were purchased from Acros Organics.  
Agmatine sulfate was purchased from Fluka (> 99%) or Sigma-Aldrich (> 97%), and was 
recrystallized from water/ethanol (1.4:1 v/v).  N-hydroxysuccinimide (98%) and N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride were purchased from Sigma-Aldrich.  
All other reagents were purchased from Fisher Scientific at the highest purity available.  pMAA 
with average-number molecular weight (Mn) of 8,100 and polydispersity index (PDI) of 1.24 was 
synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization as 
previously reported by our group25.  pAA was synthesized analogous to pMAA by RAFT 
polymerization with the exception of [AA]0 = 3.0 mol L-1 and the purification process.  Instead 
of precipitation in diethyl ether as for pMAA, pAA was purified by drying under vacuum for 10 
min to remove ~50% of the methanol and diluting with deionized-water, followed by dialysis 
using Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa MWCO) against deionized-
water for 3 days.  Samples were subsequently lyophilized for 24 h.  Initial reactant ratios were 
varied to obtain polymers with different Mn; [AA]0:[I]0:[CTA]0 = 110:0.25:1 corresponded to Mn 
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= 10,400 (PDI = 1.20), [AA]0:[I]0:[CTA]0 = 350:0.25:1 corresponded to Mn = 33,200 (PDI = 
1.21), and [AA]0:[I]0:[CTA]0 = 620:0.25:1 corresponded to Mn = 55,100 (PDI = 1.23).  Mn values 
for pAA were calculated based on pMAA standards. 
3.2.2 Gal and Agm conjugation to pMAA or pAA using DMTMM.  A representative example 
for 40% targeted Gal conjugation to pMAA which corresponds to [COOH]0:[DMTMM]0:[Gal]0 
= 1:0.4:0.8 (Table 3.1, entry 1) is as follows: In a 10 mL pear-shaped flask equipped with a 
magnetic stir bar, pMAA (24 mg, 0.28 mmol repeating units) and Gal (47 mg, 0.22 mmol) were 
dissolved with 6 mL of 0.1 M borate buffer, pH = 8.5.  After 10 min under stirring, a DMTMM 
solution (30 mg, 0.11 mmol; in 2 mL of 0.1 M borate buffer, pH = 8.5) was transferred dropwise, 
and the pH was adjusted to 6.7 with additions of 1 N hydrochloric acid (HCl).  The reaction flask 
was capped with a rubber septum and continuously stirred (600 rpm) for 24 h at room 
temperature.  The product was purified by dialysis using Spectra/Por regenerated cellulose 
dialysis tubing (3.5 kDa MWCO) against 0.001 M borate buffer (pH = 8.5) for 2 days and 
deionized-water for 2 additional days and lyophilized for 24 h.  The ligand content relative to the 
total repeating units (or side chains) in each polymer was determined by 1H NMR and is referred 
to as a percentage value.  For example, pMAA-12%Gal means 12% of the total side chains in 
pMAA are grafted with a pendant Gal.  Agm conjugations to pMAA, Gal conjugations to pAA 
and Agm conjugations to pAA followed the same procedure as previously described with the pH 
adjusted to 9.1, 7.0 and 8.0, respectively, by additions of 1 N HCl or 1 N sodium hydroxide 
(NaOH).  For Agm conjugations to pMAA and pAA, the product was purified by dialysis using 
Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa MWCO) against 0.001 M HCl (pH~3) 
for 2 days and deionized-water for 2 additional days and lyophilized for 24 h.   
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3.2.3 Gal and Agm conjugation to pMAA using EDC/NHS.  The conjugation of amine-
containing ligands to pMAA using EDC/NHS was modified from previously established 
protocols13.  A representative example for 100% targeted Gal conjugation to pMAA which 
corresponds to [COOH]0:[EDC]0:[NHS]0:[Gal]0 = 1:1:2.5:5 (Table 3.1, entry 11) is as follows: In 
a 25 mL pear-shaped flask equipped with a magnetic stir bar, pMAA (20 mg, 0.23 mmol 
repeating units) was dissolved with 6 mL of 0.05 M MES, 0.5 M NaCl buffer, pH 6.5.  After 
complete dissolution, EDC (44mg, 0.23 mmol; in 2 mL of 0.05 M MES, 0.5 M NaCl buffer, pH 
6.5) and NHS (67mg, 0.58 mmol; in 2 mL of 0.05 M MES, 0.5 M NaCl buffer, pH 6.5) solutions 
were sequentially added to the reaction, and the pH was adjusted to 6.5 with additions of 1 N 
NaOH.  The reaction flask was capped with a rubber septum and continuously stirred (600 rpm) 
for 1 h at room temperature after which a Gal solution (248 mg, 1.15 mmol; in 2mL of 0.1 M 
phosphate buffer, pH 7.5 was transferred dropwise.  The pH was readjusted to 7.5 with additions 
of 1 N NaOH, and the reaction was allowed to continuously stir overnight (600 rpm) at room 
temperature.  The product was purified by dialysis using Spectra/Por regenerated cellulose 
dialysis tubing (3.5 kDa MWCO) against 0.001 M phosphate buffer (pH = 7.5) for 2 days and 
deionized-water for 2 additional days and lyophilized for 24 h.  The ligand content relative to the 
total repeating units (or side chains) in each polymer was determined by 1H NMR and is referred 
to as a percentage value.  Agm conjugations to pMAA were carried out under the same reaction 
conditions.  The product was purified by dialysis using Spectra/Por regenerated cellulose dialysis 
tubing (3.5 kDa MWCO) against 0.001 M HCl (pH~3) for 2 days and deionized-water for 2 
additional days and lyophilized for 24 h.   
3.2.4 Sequential conjugation of Gal or Agm to pMAA-graft-Gal, pAA-graft-Gal or pAA-
graft-Agm using DMTMM.  A representative example for 50% targeted Agm conjugation to 
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available carboxyl groups in pMAA-12%Gal which corresponds to 
[COOH]0:[DMTMM]0:[Agm]0 = 1:0.5:1 (Table 3.5, entry 1) is as follows: In a 10 mL pear-
shaped flask equipped with a magnetic stir bar, pMAA-12%Gal (24 mg, 0.20 mmol COOH) and 
Agm (46 mg, 0.20 mmol) were dissolved with 6 mL of 0.1 M borate buffer, pH = 8.5.  After 10 
min under stirring, a DMTMM solution (28 mg, 0.10 mmol; in 2 mL of 0.1 M borate buffer, pH 
= 8.5) was transferred dropwise, and the pH was adjusted to 9.1 with additions of 1 N NaOH.  
The reaction flask was capped with a rubber septum and continuously stirred (600 rpm) for 24 h 
at room temperature.  The product was purified by dialysis using Spectra/Por regenerated 
cellulose dialysis tubing (3.5 kDa MWCO) against 0.001 M HCl (pH~3) for 2 days and 
deionized-water for 2 additional days and lyophilized for 24 h. The ligand content relative to the 
total repeating units (or side chains) in each polymer was determined by 1H NMR and is referred 
to as a percentage value.  Agm conjugations to pAA-graft-Gal and Gal conjugations to pAA-
graft-Agm followed the same procedure as previously described with the pH adjusted to 8.0 and 
7.0, respectively, by additions of 1 N HCl or 1 N NaOH.  For Gal conjugations to pAA-graft-
Agm, the product was purified by dialysis using Spectra/Por regenerated cellulose dialysis tubing 
(3.5 kDa MWCO) against 0.001 M borate buffer (pH = 8.5) for 2 days and deionized-water for 2 
additional days and lyophilized for 24 h.   
3.2.5 Simultaneous conjugation of Gal and Agm to pAA using DMTMM.  A representative 
example for 25% targeted Gal and 75% targeted Agm conjugations to pAA which corresponds to 
[COOH]0:[DMTMM]0:[Gal]0:[Agm]0 = 1:1:0.25:0.75 (Table 3.6, entry 1) is as follows: In a 10 
mL pear-shaped flask equipped with a magnetic stir bar, pAA (24 mg, 0.33 mmol repeating 
units, Gal (18 mg, 0.083 mmol) and Agm (57 mg, 0.25 mmol) were dissolved with 6 mL of 0.1 
M borate buffer, pH = 8.5.  After 10 min under stirring, a DMTMM solution (91 mg, 0.33 mmol; 
59 
in 2 mL of 0.1 M borate buffer, pH = 8.5) was transferred dropwise, and the pH was adjusted to 
7.0 with additions of 1 N HCl.  The reaction flask was capped with a rubber septum and 
continuously stirred (600 rpm) for 24 h at room temperature.  The product was purified by 
dialysis using Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa MWCO) against 0.001 
M HCl (pH~3) for 2 days and deionized-water for 2 additional days and lyophilized for 24 h.  
The ligands content relative to the total repeating units (or side chains) in each polymer was 
determined by 1H NMR and is referred to as a percentage value.   
3.2.6 NMR spectroscopy.  1H NMR spectra of polymer conjugates were obtained using an 
Inova 400MHz spectrometer.  2-D DOSY NMR spectra of polymer conjugates were obtained 
using an Inova 600MHz spectrometer.  Deuterium oxide (D2O) was used as the solvent.  To the 
samples that were not readily soluble in D2O, small additions of deuterium chloride or sodium 
deuteroxide (30% wt. in D2O) were added.  Resonances were referenced to HOD at 4.81 ppm.    
 
3.3 Results and discussions  
 The effective design of polymeric libraries with a range of functionalities requires careful 
characterization of the conjugation process, which is greatly influenced by the polymer precursor 
and selected ligands.  In this study, we evaluate two polymer backbones, pMAA and pAA.  Both 
polymers are readily soluble in water and can easily undergo chemical modifications.  The high 
content of carboxyl groups from the side chains allows diverse combinations of multiple pendant 
groups grafted to the polymer backbone via amide bonds.  However, these related but 
structurally different polymers showed significant differences in conjugation efficiencies of our 
two model ligands, Gal and Agm, which sparked our interest to investigate the trends 
distinguished for such conjugations under various conditions. 
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3.3.1 NMR analyses for Gal and Agm conjugation to pMAA or pAA.  The side chains of 
both pMAA and pAA were modified by the substitution of Gal and Agm using DMTMM as the 
condensing agent (Figure 3.1).  DMTMM activates the carboxyl groups in the polymer by 
forming a 2-acyloxy-4,6-dimethoxy-1,3,5-triazine intermediate followed by the nucleophilic 
attack of the amino group resulting in an amide linkage between the polymer side chains and the 
ligand of interest19.   
 The degree of side chain substitution was determined from the peak intensity ratio of the 
polymer backbone to the side chain groups by 1H NMR (Inova 400MHz) spectroscopy with D2O 
as the solvent, and is referred to as a percentage value.  Figure 3.2(A-C) shows the 1H NMR 
spectra for pMAA-20%Gal, pMAA-37%Agm and pMAA-18%Gal-24%Agm, respectively.  The 
chemical shift for the protons in the α-methyl group (-CH3) in the polymer backbone of pMAA 
are distinguished at 0.6-1.4 ppm (peak a) while the protons of the methylene group (-CH2) are at 
1.4-2.3 ppm (peak b).  Gal has distinctive chemical shifts at 3.5-4.7 ppm corresponding to 6H 
along the ring structure at C-2 to C-6 positions and at 5.2 ppm corresponding to 1H at C-1 
position (peaks d).  Similarly, Agm proton chemical shifts are located at 1.6 ppm for 4H (peak f) 
and at 3.2 ppm for 4H (peak e).  Figure 3.2(D-F) illustrates the 1H NMR spectra for pAA-
56%Gal, pAA-30%Agm and pAA-56%Gal-33%Agm, respectively.  In the case of pAA and 
pAA conjugates, the pAA backbone protons have chemical shifts of 1.2-2.0 ppm (peak b) and 
2.0-2.8 ppm (peak c) for the methylene (-CH2) and methyne group (-CH), respectively.  Grafted 
Gal and Agm to pAA have chemical shifts analogous to the pMAA conjugates.  However, for 
pAA, an unexpected peak was observed at 3.7 ppm.  Further analysis revealed that this peak was 
from methanol esterification of the carboxylic acid during RAFT polymerization.  The peak was 
accounted for the quantitation of Gal substitution in pAA.     
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Figure 3.1: Synthesis schematic for condensation reaction of pMAA or pAA and amine-
containing ligand (Gal and Agm) using DMTMM as the condensing agent.   
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Figure 3.2:  1H NMR spectra (400 MHz, D2O) of (A) pMAA-20%Gal, (B) pMAA-37%Agm, 
(C) pMAA-18%Gal-24%Agm, (D) pAA-56%Gal, (E) pAA-30%Agm, and (F) pAA-56%Gal-
33%Agm.  Peaks: (a) and (b) pMAA backbone; (b) and (c) pAA backbone; (d) Gal; (e) and (f) 
Agm.  pMAA Mn = 8,100 (PDI = 1.24); pAA Mn = 10,400 (PDI = 1.20).   
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Because of the cationic nature of Agm, the removal of excess Agm from the reaction was 
performed through dialysis against an acidic environment (pH~3).  To corroborate the absence of 
unconjugated ligand in the final product, diffusion-ordered spectroscopy (DOSY) was carried out 
for both pMAA and pAA conjugates.  DOSY is a pulsed field gradient NMR experiment in 
which species in a mixture are distinguished by their translational diffusion coefficients.  Figure 
3.3 shows a representative example of the 2-D DOSY NMR spectrum in D2O for pAA-56%Gal-
33%Agm that demonstrates that both ligands are covalently attached to the polymer side chains 
and that no residual ligands or byproducts remained in solution after dialysis.  In the spectrum 
generated, the diffusion coefficients have arbitrary units; however, it is important to note that all 
species in the polymer have the same translational diffusion and that this diffusion is much 
slower than water (HOD peak), a much smaller molecule.  Similar results were obtained for 
pMAA conjugates. 
3.3.2 Effect of pH on Gal and Agm conjugation to pMAA.  The extent to which both Gal and 
Agm conjugate to pMAA is influenced by the pH of the selected buffer.   It was previously 
established that prior to the addition of DMTMM to the reaction, both the carboxylic acid and 
the amine should be pre-mixed to form an ammonium carboxylate salt19.  Formation of this salt 
can also be enhanced by maintaining the pH of the aqueous solution between the acid 
dissociation constants (pKa) of both the acid and the amine of interest.  The pKa for the amino 
group in Gal is 8.49 and 8.02 for the α- and β- configuration, respectively26, while for the amino 
group in Agm is 9.0727.  The pKa for weak polyacids varies depending on the solution conditions 
and polymer structure.  A titration curve of pMAA with NaOH revealed a functional pKa of 6.3.  
Based on this information, the pH range that is likely most favorable for Gal conjugation to 
pMAA is from 6.3 to 8 and for Agm conjugation to pMAA is from 6.3 to 9.  In addition, at these  
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Figure 3.3:  2-D DOSY NMR spectrum (600 MHz, D2O) of pAA-56%Gal-33%Agm.  Chemical 
shifts and relative diffusion coefficients are shown along the horizontal and vertical axes, 
respectively.  pAA Mn = 10,400 (PDI = 1.20).   
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pH values the polymer chain is in an extended conformation due to the charge repulsion from the 
carboxylate groups along the polymer backbone.  Figure 3.4A shows the relationship of 
conjugation efficiency for both Gal and Agm as a function of pH.  The conjugation efficiency 
was calculated from the molar ratio of actual ligand content in the polymer to targeted 
substitution.  pMAA-Agm conjugates experienced solubility issues mostly in acidic 
environments, and the pH range at which these conjugates were soluble directly depended on the 
degree of Agm substitution.  Moreover, reactions conducted at pH 8 formed conjugates that 
precipitated out of solution and were not able to be properly analyzed (represented by dashed 
line in Figure 3.4A).  From this analysis, it was determined that the optimal pH in 0.1 M borate 
buffer for the highest conjugation efficiency of Gal and Agm to pMAA was 6.7 and 9.1, 
achieving a maximum conjugation efficiency of 20% and 37%, respectively.    
3.3.3 Effect of pH on Gal and Agm conjugation to pAA.  pAA’s behavior in aqueous media is 
remarkably different from pMAA.  A titration curve for pAA generated with NaOH reflected a 
functional pKa of 5.9 which gives a slightly larger pH range for effective conjugation as 
compared to pMAA.  The optimal pH in 0.1 M borate buffer was found to be 7.0 and 8.0, 
corresponding to conjugation efficiencies of 52% and 57% for Gal and Agm conjugation to 
pAA, respectively (Figure 3.4B).  Interestingly, although the pAA structure is comparable to 
pMAA, the conjugation efficiencies for pAA were significantly higher (2.6- and 1.5-fold for Gal 
and Agm, respectively) at their optimal pH values.  The lack of an α-methyl group in the pAA 
backbone may have permitted higher conjugation efficiencies relative to pMAA. 
 During Agm and Gal conjugations to both pMAA and pAA, the solution pH was noticed 
to decrease to ~ 6.5-8.5 as the reaction proceeded.  At these pH values, amine groups will have a 
lower reactivity toward the ester intermediate.  However, increasing the pH to 8 or 9 after 5 h of  
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Figure 3.4:  Relationship of conjugation efficiency with pH (adjusted at t = 0 h) in 0.1 M borate 
buffer using DMTMM as the condensing agent: (A) (■) pMAA-graft-Agm and  (●) pMAA-
graft-Gal.  Dashed lines represents the pH range that was not analyzed due to precipitation of the 
polymer conjugates; (B) (■) pAA-graft-Agm and  (●) pAA-graft-Gal.  Reactions were 
conducted at room temperature for 24 h with [polymer]0 = 3 mg/mL and 
[COOH]0:[DMTMM]0:[NH2]0 = 1:1:2.  Data was generated from an average of two repetitions 
with standard error < 6%.  pMAA Mn = 8,100 (PDI = 1.24); pAA Mn = 10,400 (PDI = 1.20).   
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reaction to favor the deprotonation of the amine groups and enhance reactivity toward the ester 
intermediate did not have a positive impact on the conjugation efficiency leading to equal or 
lower Gal and Agm substitutions in both pMAA and pAA (data not shown).  It is possible that 
the ester intermediate begins to hydrolyze before the amidation reaction completely takes place, 
as also suggested by the lower conjugation efficiencies for reactions carried out at higher pH 
values (Figure 3.4).  
3.3.4 Single conjugation of Gal and Agm to pMAA or pAA.  Table 3.1 includes the actual 
ligand substitutions of Gal and Agm in pMAA and conjugation efficiencies at various 
[COOH]0:[DMTMM]0 molar ratios.  The conjugation efficiency was calculated from the molar 
ratio of actual ligand substitution to targeted substitution, which is determined from the 
[DMTMM]0 to [COOH]0 molar ratio.  From this data, a noticeable trend is distinguished in 
which the conjugation efficiency decreases as the reactant ratios of [DMTMM]0 and [NH2]0 
relative to [COOH]0 increases, likely due to steric hindrance.  This behavior is observed for both 
Gal and Agm conjugations to pMAA.  The highest conjugation efficiencies obtained with 
DMTMM were 30% for Gal and 53% for Agm; however, this was when only 40% of the 
carboxyl groups in pMAA were targeted.      
 For a direct comparison to other common conjugation reagents, an analogous chemical 
modification using EDC/NHS was performed.  Similar results were obtained at comparable 
targeted substitutions further suggesting that the polymer and/or ligand structure might be in part 
responsible for this relatively low conjugation efficiency.  Maximum total ligand substitutions 
(mol %) of 23% Gal and 53% Agm were achieved for pMAA.  Decreasing the polymer 
concentration 3-fold had a negative impact on the conjugation efficiency particularly for Agm 
substitution which  was reduced  by half its value.     Potential   reasons  for   such     conjugation  
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Table 3.1: Gal and Agm conjugation to pMAAa 
Entry Ligand Condensing agent 
[pMAA]0 
(mg/mL) 
[COOH]0: 
[condensing 
agent]0  
(mol L-1) 
Actual 
substitution 
(AS)b (%) 
Conjugation 
efficiency 
(CE)c (%) 
1 Gald DMTMM 3 1:0.4 12 30 
2 Gald DMTMM 3 1:0.7 18 26 
3 Gald DMTMM 3 1:1 20 20 
4 Gald DMTMM 3 1:2 23 12 
5 Gald DMTMM 1 1:1 16 16 
       
6 Agme DMTMM 3 1:0.4 21 53 
7 Agme DMTMM 3 1:0.7 30 43 
8 Agme DMTMM 3 1:1 37 37 
9 Agme DMTMM 3 1:2 53 27 
10 Agme DMTMM 1 1:1 17 17 
       
11 Galf EDC 2 1:1 26 26 
12 Galf EDC 2 1:2 30 15 
       
13 Agmf EDC 2 1:1 25 25 
14 Agmf EDC 2 1:2 28 14 
 
aReactions were conducted at room temperature for 24 h.  pMAA Mn = 8,100 (PDI = 1.24). bAs determined by 1H 
NMR (400MHz) with D2O as the solvent.  cAs calculated by CE = AS/([condensing agent]0/[COOH]0).  dReactions 
were conducted in 0.1 M borate buffer, pH 6.7 with [NH2]0 = 2·[DMTMM]0. eReactions were conducted in 0.1 M 
borate buffer, pH 9.1 with [NH2]0 = 2·[DMTMM]0.  fReactions were conducted in a final concentration of 0.042M 
MES, 0.42M NaCl and 0.017M phosphate buffer, pH 7.5 with [NH2]0 = 5·[EDC]0 and [NHS]0 = 2.5·[EDC]0. 
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deficiencies might be the chemical characteristics of the polymer and/or ligands, or the short 
distance between the side chain carboxyl groups and polymer backbone along with the α-methyl 
group in the polymer backbone which can generate steric hindrance.  Previous work by Kazakov 
and collaborators14,28 demonstrated that pMAA has a local compact conformation at pH < 5 in 
part due to the hydrophobic methyl groups attached to the polymer chain.  This suggests that the 
α-methyl group in the polymer backbone has an important role in the conformation of this 
polymer in solution, and this may influence its ability to interact with other moieties.    
 In contrast to pMAA, pAA achieved much higher conjugation efficiencies leading to 
higher total ligand contents under equivalent conditions.  The highest total ligand substitutions 
(mol %) obtained for pAA were 56% Gal and 78% Agm (Table 3.2).  Compared to pMAA, a 
similar decreasing trend of conjugation efficiency with increasing targeted substitution was 
observed for both Gal and Agm conjugations to pAA, likely due to steric hindrance.  It is evident 
that for both polymer precursors, Agm was more readily incorporated into the polymer side 
chains than Gal.  The low   Gal conjugation efficiency may be due to its relatively large, ring-like 
structure which may cause steric hindrance as compared to the more elongated structure of Agm.
 The solubility in aqueous solution of both pMAA-Agm and pAA-Agm conjugates was 
found to be directly affected by degree of substitution of the ligand (Table 3.3).  Agm substituted 
to less than half of the available carboxyl groups in the polymer will lead to solubility issues in 
more acidic environments.  In contrast, Agm substituted to more than half of the available 
carboxyl groups in the polymer will experience solubility issues in more basic environments.  
For instance, by visual inspection, pMAA-25%Agm is insoluble at 3 < pH < 5.8 and pMAA-
37%Agm is insoluble at 3 < pH < 6.8, while pMAA-53%Agm is insoluble at pH > 4.9.  
Similarly for pAA-Agm conjugates,    pAA-30%Agm is insoluble at 3 < pH < 5.9,    while pAA-   
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Table 3.2: Gal and Agm conjugation to pAAa 
Entry Ligand [pAA]0 (mg/mL) 
[COOH]0:[DMTMM]0:
[NH2]0 (mol L-1) 
Actual 
substitution 
(AS)b (%) 
Conjugation 
efficiency 
(CE)c (%) 
1 Gald 3 1:0.5:1 35 70 
2 Gald 3 1:0.7:1.4 41 59 
3 Gald 3 1:1:2 52 52 
4 Gald 3 1:2:4 56 28 
5 Gald 1 1:1:2 43 43 
      
6 Agme 3 1:0.5:1 30 60 
7 Agme 3 1:0.7:1.4 46 66 
8 Agme 3 1:1:2 57 57 
9 Agme 3 1:2:4 78 39 
10 Agme 1 1:1:2 32 32 
 
aReactions were conducted at room temperature for 24 h using DMTMM as the condensing agent with [NH2]0 = 
2·[DMTMM]0.  pAA Mn = 10,400 (PDI = 1.20).  bAs determined by 1H NMR (400MHz) with D2O as the solvent.  
cAs calculated by CE = AS/([DMTMM]0/[COOH]0).  dReactions were conducted in 0.1 M borate buffer, pH 7.0.  
eReactions were conducted in 0.1 M borate buffer, pH 8.0.   
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Table 3.3: Solubility of pMAA and pAA conjugates (by visual inspection) 
 
 
 
 
 
 
 
 
 
 
 
 
Entry % Ligand pH where samples are soluble 
pMAA conjugates 
1 53% Agm pH < 4.9 
2 37% Agm pH > 6.8, pH < 3 
3 25% Agm pH > 5.8, pH < 3 
4 12% Gal Soluble at all pH 
5 18% Gal Soluble at all pH 
6 20% Gal Slightly opaque at all pH 
pAA conjugates 
7 78% Agm Soluble at all pH 
8 57% Agm  pH < 8 
9 30% Agm pH > 5.9, pH < 3 
10 52% Gal Soluble at all pH 
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57%Agm is insoluble at pH > 8.  pAA-78%Agm remains soluble at all pHs.  These overall pH 
behaviors are likely due to the presence of both positive and negative charges in the polymer, 
which at specific pHs cause electrostatic interactions between the charged polymers chains, 
leading to aggregation and altered solubility.  Polymers with lower Agm substitution (< 
50%) become soluble at higher pH values as the available carboxyl groups undergo ionization 
providing a net negative charge which reduces electrostatic interactions between the polymer 
chains.  On the contrary, polymers with higher Agm substitution (> 50%), become soluble at 
lower pH values as the available carboxyl groups become protonated generating a net positive 
charge that reduces electrostatic interaction between the polymer chains.  The higher the Agm 
substitution, the more soluble these conjugates become due to a net positive charge in the 
polymer regardless of the degree of ionization of the available carboxyl groups, as distinguished 
for pAA-78%Agm.  Aggregation of polymer conjugates at certain pHs was confirmed through 
dynamic light scattering.  Figure 3.5 shows the relationship of mean particle diameter (Z-
average, nm) with pH for pMAA-37%Agm (A) and pAA-57%Agm (B).  pMAA-37%Agm 
shows aggregation at pH 3-7 while pAA-57%Agm shows aggregation at pH > 8.  
 For pMAA-Gal conjugates, only relatively high Gal substitution (> 20%) produced 
solubility issues.  However, these were on a much smaller scale and were accompanied by a light 
opaqueness of the polymer solution at all pH ranges.  pAA-Gal conjugates did not show any 
solubility issues regarding the Gal total content, corroborating the role of the cationic charge 
produced by Agm in solubility issues and aggregation.   
 To evaluate the impact of the polymer molecular weight on the conjugation efficiency of 
the ligands, various Agm and Gal conjugations were carried out with pAA of higher Mn, 
specifically 33,100 Da  and 55,200 Da.  Solubility issues were  more  prominent  with  increasing  
73 
 
 
 
 
 
Figure 3.5:  Relationship of mean particle diameter (Z-average, nm) with pH in 0.1 M borate 
buffer.  Instruments: Malvern Zetasizer Nano-ZS.  Data was generated from three measurements, 
each consisting of 10 runs of 10 s each.  Error bars represents standard deviations from those 
three measurements.  (A) pMAA-37%Agm; (B) pAA-57%Agm. 
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polymer Mn for pAA-Agm conjugates.  As the reaction progressed, these polymer conjugates 
precipitated out of solution, in which case, they were acidified until fully dissolved prior to 
dialysis.  Total ligand content and conjugation efficiencies were consistent with those values for 
lower Mn polymers (Table 3.4).  To aid the solubility of these polymer conjugates, equivalent 
reactions were carried out at a lower initial pH (pH 6).  However, conjugation efficiencies were ~ 
40% lower than the reactions carried out at an initial pH of 8, and solubility issues were still 
present (data not shown).     
 In addition to the ease in preparation of single-step reactions and the mild reaction 
conditions, another significant advantage of post-polymerization modifications mediated by 
DMTMM is its reproducibility.  For single conjugations of Gal or Agm to pMAA and pAA, 70% 
of the conditions were repeated at least twice and up to four times, all with standard errors < 6%.  
This attribute provides a batch-to-batch consistency that is important to reduce variability of the 
final product.   
3.3.5 Sequential conjugation of Gal and Agm to pMAA or pAA.  Owing to their different 
optimal conjugation characteristics, simultaneous conjugation of both Gal and Agm to pMAA 
was not viable in a one-step reaction.  Following a single-step conjugation containing both 
ligands, Agm was the only ligand efficiently conjugated, limiting Gal substitution in the polymer 
side chains (data not shown).  Moreover, Gal was unable to be subsequently incorporated in high 
amounts into pMAA-graft-Agm, making a two-step reaction, where Gal was first introduced to 
the polymer followed by Agm, the most favorable route to having both groups present.  The 
corresponding substitutions and conjugation efficiencies of the two-step approach are shown in 
Table 3.5.  In contrast to pMAA, both Gal and Agm were able to conjugate to pAA sequentially.  
For both polymers, similar to single conjugations, the conjugation efficiency decreased as higher 
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Table 3.4: Gal and Agm conjugation to pAA of different molecular weights (Mn )a 
aReactions were conducted at room temperature for 24 h using DMTMM as the condensing agent.  bAs determined 
by 1H NMR (400MHz) with D2O as the solvent.  cAs calculated by CE = AS/([DMTMM]0/[COOH]0).  dReactions 
were conducted in 0.1 M borate buffer, pH 7.0.  eReactions were conducted in 0.1 M borate buffer, pH 8.0.   
 
 
 
 
 
 
 
 
 
Entry pAA Mn 
(Da) 
Ligand [COOH]0:[DMTMM]0:[NH2]0 
(mol L-1) 
Actual 
substitution 
(AS)b (%) 
Conjugation 
efficiency 
(CE)c (%) 
1 33,200 Gald 1:1:2 52 52 
2 33,200 Gald 1:2:4 60 30 
3 33,200 Agme 1:1:2 56 56 
4 33,200 Agme 1:2:4 77 39 
      
5 55,100 Gald 1:1:2 49 49 
6 55,100 Gald 1:2:4 60 30 
7 55,100 Agme 1:1:2 50 50 
8 55,100 Agme 1:2:4 75 38 
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Table 3.5: Sequential conjugation of Agm to pMAA-graft-Gal and pAA-graft-Gal, and of Gal to 
pAA-graft-Agma 
 
aReactions were conducted at room temperature for 24 h using DMTMM as the condensing agent with [NH2]0 = 
2·[DMTMM]0 and [polymer]0 = 3 mg/mL.  pMAA Mn = 8,100 (PDI = 1.24); pAA Mn = 10,400 (PDI = 1.20).  bAs 
determined by 1H NMR (400MHz) with D2O as the solvent.  cAs calculated by CE = AS/(([DMTMM]0/[COOH]0) · 
XCOOH), where XCOOH  is the fraction of available COOH groups in a polymer chain.  dReactions were conducted in 
0.1 M borate buffer, pH 9.1.  eReactions were conducted in 0.1 M borate buffer, pH 8.0.  fReactions were conducted 
in 0.1 M borate buffer, pH 7.0.  
 
Entry Polymer 
[COOH]0:[DMTMM]0:
[NH2]0 (mol L-1) 
Ligand 
Actual 
substitution 
(AS)b (%) 
Conjugation 
efficiency 
(CE)c (%) 
1 pMAA-12%Gald 1:0.5:1 Agm 13 30 
2 pMAA-12%Gald 1:0.8:1.6 Agm 21 30 
3 pMAA-12%Gald 1:1.1:2.2 Agm 24 25 
4 pMAA-18%Gald 1:0.5:1 Agm 15 37 
5 pMAA-18%Gald 1:0.8:1.6 Agm 20 30 
6 pMAA-18%Gald 1:1.2:2.4 Agm 24 24 
7 pMAA-20%Gald 1:0.5:1 Agm 16 40 
8 pMAA-20%Gald 1:0.8:1.6 Agm 20 31 
9 pMAA-20%Gald 1:1.2:2.4 Agm 24 25 
      
10 pAA-35%Gale 1:0.5:1 Agm 12 37 
11 pAA-35%Gale 1:1.1:2.2 Agm 24 34 
12 pAA-35%Gale 1:4.8:9.6 Agm 42 13 
13 pAA-56%Gale 1:0.5:1 Agm 6 27 
14 pAA-56%Gale 1:1.1:2.2 Agm 10 21 
15 pAA-56%Gale 1:5.7:11.4 Agm 33 13 
      
16 pAA-30%Agmf 1:0.6:1.2 Gal 20 48 
17 pAA-30%Agmf 1:1.3:2.6 Gal 26 29 
18 pAA-30%Agmf 1:6.8:13.6 Gal 35 7 
19 pAA-46%Agmf 1:2.7:5.4 Gal 14 10 
20 pAA-46%Agmf 1:6.8:13.6 Gal 26 7 
21 pAA-57%Agmf 1:1.1:2.2 Gal 4 8 
22 pAA-57%Agmf 1:4.3:8.6 Gal 8 4 
23 pAA-78%Agmf 1:5:10 Gal 3 3 
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substitutions were targeted, possibly due to an increase in steric hindrance produced by the 
neighboring pendant groups.  Although lower conjugation efficiencies relative to single 
substitutions were obtained, the versatility of pAA to incorporate both moieties likely makes it a 
more suitable polymer for this type of conjugation, particularly when a high content of a 
positively charged moiety (i.e. Agm) is desired.    
3.3.6 Simultaneous conjugation of Gal and Agm to pAA.  In contrast to pMAA, Agm and Gal 
were able to conjugate simultaneously to pAA with comparable overall efficiency to single 
conjugations (Table 3.6).  A pH of 7 was selected to accommodate both Gal and Agm 
conjugations to pAA resulting in the effective substitution of both groups.  The flexibility of 
simultaneous conjugation to pAA offers vast possibilities for dual-functionalization and perhaps 
multiple simultaneous conjugations of other ligands to these polymer precursors.   
  
3.4 Conclusions 
 Both pMAA and pAA were modified by the side chain substitution of Gal and Agm at 
various ratios.  A nearly two-fold increase in conjugation efficiencies for both ligands to pAA 
was achieved as compared to pMAA under identical conditions reaching up to 56% and 80% of 
Gal and Agm of total content, respectively.  The low side chain substitution of Agm, the cationic 
source, to pMAA caused these polymers to be unable to effectively interact with negatively 
charged siRNA.  Therefore, due to the higher Agm/Gal substitutions relative to pMAA, pAA 
conjugates were selected for evaluation as siRNA delivery vectors.  By varying the [pAA]0 to 
[DMTMM]0 molar ratio, various Agm/Gal binary combinations were achieved for each polymer 
precursor.  A total of 22 polymer conjugates were evaluated for in vitro siRNA delivery. 
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Table 3.6: Simultaneous conjugation of Gal and Agm to pAAa 
 
aReactions were conducted in 0.1 M borate buffer, pH 7.0 at room temperature for 24 h using DMTMM as the 
condensing agent with [polymer]0 = 3 mg/mL.  pAA Mn = 10,400 (PDI = 1.20).  AS = actual substitution. CE = 
conjugation efficiency.  bAs determined by 1H NMR (400MHz) with D2O as the solvent.  cAs calculated by CEGal = 
ASGal/([Gal]0/[COOH]0) and CEAgm = ASAgm/([Agm]0/[COOH]0).  dAs calculated by CEoverall = 
(ASGal+ASAgm)/([DMTMM]0/[COOH]0). 
 
 
 
 
 
 
 
 
 
 
 
Entry [COOH]0:[DMTMM]0:[Gal]0:[Agm]0         (mol L-1) 
Gal:Agm AS 
(ASGal:ASAgm)b 
(%) 
Gal:Agm CE 
(CEGal:CEAgm)c 
(%) 
Overall CE 
(CEoverall)d 
(%) 
1 1:1:0.25:0.75 13:39 52:52 52 
2 1:1:0.5:0.5 27:28 54:56 55 
3 1:1:0.75:0.25 36:17 48:68 53 
4 1:1:1:1 30:30 30:30 60 
5 1:2:1:1 38:32 38:32 35 
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CHAPTER 4 
COMBINATORIAL LIBRARY OF BI-FUNCTIONAL POLYMERIC VECTORS FOR 
siRNA DELIVERY IN VITRO 
 
4.1 Introduction 
 The discovery of RNA interference1 (RNAi) has led to a revolution in molecular biology 
and disease treatment.  RNAi is a highly regulated post-transcriptional mechanism that 
modulates protein expression within cells, and has become extremely attractive for studies 
involving protein regulation both in vitro and in vivo2-4.  By taking advantage of this endogenous 
mechanism, gene silencing can be induced by sequence-specific cleavage of a messenger RNA, 
thus reducing or eliminating undesired protein expression.  Inducing protein knockdown in 
mammalian systems can be achieved through different effectors, including synthetic small 
interfering RNA (siRNA), short hairpin RNA (shRNA) which are rapidly converted to siRNA in 
the cell cytoplasm and DNA encoding for shRNA5.  Particularly, synthetic siRNA, a 21-23 base 
pair long oligonucleotide, offers numerous advantages such as a wide range of mRNA targets 
with high specificity and localized cytoplasmic targeting without chromosomal DNA 
interference. 
 Introducing siRNA into cells is limited by numerous challenges, predominantly the lack 
of effective delivery systems that can safely transport these macromolecules to their site of action 
while overcoming a manifold of barriers hindering the delivery pathway6.  In contrast to viral 
vectors, non-viral delivery systems have become promising therapeutic alternatives due to their 
low cytotoxicity profiles, low immune response and ease in chemical modifications.  Among 
non-viral delivery systems, polymer-based vectors have increasingly gained attention primarily 
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due to the ability to tailor their architectures and consequently their physicochemical properties7-
9.  Although several drawbacks exist, such as limited cargo and impermeability through the cell 
membrane, polymeric vectors can be designed to integrate specific functionalities that provide 
beneficial properties including cell targeting, pH-responsiveness, and stability in the extracellular 
medium.  Multifunctional polymers are adaptable to address multiple design criteria for bioactive 
materials10; however, identifying optimal structural characteristics from a wide structure-
parameter space can be challenging.   
 Combinatorial libraries of polymers have become a valuable avenue for the design of 
functional biomaterials, particularly for gene delivery11-17.  Through combinatorial libraries, the 
structure-function relationship of biomaterials can be correlated to identify the most favorable 
structural parameters for optimal outcomes - these being high transfection efficiencies with 
minimal cytotoxicity.  Therefore, this combinatorial approach can be remarkably favorable for 
the development of bioactive polymers as siRNA delivery systems. 
 In this study, a combinatorial chemistry approach was employed for a rational design of 
polymeric vectors for enhanced siRNA delivery through a mechanistic understanding of their 
structure-function relationships.  Toward this goal, poly(acrylic acid) (pAA) of different 
molecular weights (Mn) was synthesized by reversible addition-fragmentation chain transfer 
(RAFT).  Based on these precursors, a library of polymers was generated by the side chain 
substitutions of two distinct moieties, D-(+)-galactosamine (Gal) and agmatine (Agm), at 
different ratios.  Agm provides a cationic source to facilitate interactions with the siRNA and 
enhance cell membrane permeability, while Gal can serve as a tissue-specific targeting ligand.  
The structural parameters examined include: (1) molecular weight (Mn) of the polymer, (2) Agm 
content, and (3) Gal content.  The biophysical and cellular characterization of these polymeric 
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vectors was carried out and herein reported.  This includes binding affinity of polymers with 
siRNA, polyplex stability in the presence of competitive ionic species (sodium heparin), 
polyplex stability in serum, polyplex effective diameter and zeta potential, cytotoxicity and 
transfection efficiency using MDA-MB-231-luc+ cells as a model cell line.  
 
4.2 Materials and methods 
4.2.1 Materials.  25 kDa branched polyethylenimine (PEIb), sodium heparin from porcine 
intestinal mucosa, fluoresceinamine (FA) and ethidium bromide (EtBr) were purchased from 
Sigma-Aldrich. Tris(2-carboxyethyl) phosphine hydrochloride (TCEP∙HCl) was purchased from 
Fisher Scientific.  HEPES buffer (10mM, pH 7.2) was prepared with ultrapure water and filtered 
through a 0.2 µm PES membrane.  TBE buffer (0.089 M Tris base, 0.089 M boric acid, and 2 
mM sodium EDTA) and SYBR green II RNA gel stain were purchased from Invitrogen.  MDA-
MB-231-luc+ cells were maintained in Dulbecco's Modified Eagle Medium (DMEM, Cellgro, 
Mediatech Inc., Manassas VA) with 10% v/v Fetal Bovine Serum (FBS, HyClone, Thermo 
Scientific) at 37°C and 5% CO2.  GL3 siRNA duplex (sense sequence 5'- CUU ACG CUG AGU 
ACU UCG A dTdT -3') and nonspecific control siRNA duplex (sense sequence 5'-AUG UAU 
UGG CCU GUA UUA G UU -3'), were purchased from Dharmacon, Thermo Scientific. 
4.2.2 Polymer conjugates.  pAA of various Mn and polymer conjugates were synthesized as 
previously reported by our group18.  Mn and PDI values for pAA were obtained using a Waters 
Gel Permeation Chromatography (GPC) system and were calculated based on poly(methacrylic 
acrylic) standards.  A library of polymers was synthesized by conjugating D-(+)-galactosamine 
(Gal) and agmatine (Agm), at different ratios, to the side chains of pAA.  The conjugation of 
these groups was mediated via a condensation reaction using 4-(4,6-dimethoxy-1,3,5-triazin-2-
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yl)-4-methylmorpholinium chloride (DMTMM) as the condensing agent.  Reactions were carried 
out in 0.1 M borate buffer, pH 7 and pH 8 for Gal and Agm conjugations, respectively, at room 
temperature for 48 h.  To obtain different ligand content, the [COOH]0 to [DMTMM]0 molar 
ratio was varied with [NH2]0 = 2·[DMTMM]0.  The degree of side chain substitution of each 
ligand (percent conjugation) in pAA was determined by 1H NMR (Inova 400MHz) spectroscopy 
with deuterium oxide (D2O) as the solvent. 
4.2.3. Fluoresceinamine conjugation to polymer conjugates.  A representative example for 
10% targeted FA conjugation to available carboxyl groups in 10kDa pAA-78%Agm-3%Gal (10-
P2) which corresponds to [COOH]0:[DMTMM]0:[FA]0 = 1:0.1:0.2 is as follows: In a 5 mL pear-
shaped flask equipped with a magnetic stir bar, 10-P2 (10 mg, 0.012 mmol COOH) and FA (0.83 
mg, 0.0024 mmol in 34 µl of DMSO) were dissolved with 2 mL of 0.1M borate buffer, pH = 8.5.  
After 10 min under stirring, a DMTMM solution (0.33 mg, 0.0012 mmol; in 1.3 ml of 0.1M 
borate buffer, pH = 8.5) was transferred dropwise, and the pH was adjusted to 7.5 with additions 
of 1N sodium hydroxide (NaOH).  The reaction flask was capped with a rubber septum and 
continuously stirred (600 rpm) for 24 h at room temperature.  The product was purified by 
dialysis using Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa MWCO) against 
deionized-water for 3 days and lyophilized for 24 h.    
4.2.4 Preparation of polyplexes.  A 0.5 mg/mL stock solution of polymer conjugates was 
prepared with 10 mM HEPES buffer, pH 7.2.  Immediately prior to formation of the polyplex, 
the polymer conjugate stock solution was sonicated for 60 s.  A specified volume of 20 µM or 2 
µM siRNA was mixed with aliquots of polymer conjugates stock solution to form the designated 
polymer:siRNA ratio (w:w).  The final volume was adjusted with 10 mM HEPES buffer, pH 7.2.  
After vortexing for 5 s, the polyplex solution was incubated at room temperature for 20 min. 
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4.2.5 Relative binding affinity and heparin competitive displacement.  The relative strength 
of electrostatic binding between siRNA and polymer conjugates and the displacement of siRNA 
from the polyplex by heparin (competitive anionic species) were measured by EtBr fluorescence 
quenching.  Stock solutions of siRNA, polymer conjugates, sodium heparin, and EtBr were 
prepared with 10 mM HEPES buffer, pH 7.2.  Polyplexes were formed as previously described.  
siRNA (20 µL of 2 µM stock solution) was combined with a specific volume of the polymer 
conjugate stock solution to achieve the designated polymer:siRNA ratio (w:w), and the final 
volume was adjusted to 120 µL.  The polyplex solution (100 µL) was transferred to a black 96-
well plate.   
 For the relative binding affinity assay, 50 µL of 14 µM EtBr solution was added to each 
well, and plates were incubated at room temperature for 20 min.  For the competitive heparin 
displacement assay, 10 µL of sodium heparin solution of varying concentrations were transferred 
to each corresponding well, and plates were incubated at 37°C for 20 min.  EtBr solution (40 µL 
of 17.5 µM stock solution) was added to each well, and plates were incubated at room 
temperature for an additional 20 min.     
 The final concentration of EtBr was 4.67 µM and the siRNA phosphate group to EtBr 
ratio was 2:1.  Fluorescence was read using a Molecular Devices SpectraMax GeminiEM at λexc  
= 535 and λemi = 595 nm.  Each condition was performed in triplicate.  
4.2.6 Polyplex stability in serum.  The stability of polyplexes in the presence of serum proteins 
was evaluated as previously described19.  Briefly, polyplexes were formed as previously 
described.  siRNA (18.8 µL of 20 µM stock solution) was combined with a specific volume of 
the polymer conjugate stock solution to achieve the designated polymer:siRNA ratio (w:w), and 
the final volume was adjusted to 200 µL.  Polyplexes were incubated at 37 °C with equal volume 
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of DMEM with 20% v/v FBS.  The FBS final concentration was 10% v/v.  At the designated 
times (0, 1, 2, 4, 8, 16, 24 and 48 h), an aliquot of the polyplex solution (40 µL) was removed, 
frozen with liquid nitrogen and stored at -80 °C.  To terminate serum activity and dissociate the 
siRNA from the complex, samples were incubated at 80 °C for 5 min and sodium heparin (5 µL 
of 1 mg/mL stock solution) was added, respectively.  The integrity of the siRNA was assessed by 
electrophoresis using a 15% TBE-urea polyacrylamide gel (Invitrogen) at a constant voltage of 
200 V for 1 h in 1x TBE buffer.  Gels were incubated for 40 min in SYBR green II RNA gel 
stain (1:10,000 dilution in filtered water), and siRNA bands were visualized under a UV 
transilluminator (λ = 302 nm).  
4.2.7 Effective diameter and zeta potential.  Polyplexes were formed as previously described.  
siRNA (19.8 µL of 20 µM stock solution) was combined with a specific volume of the polymer 
conjugate stock solution to achieve the designated polymer:siRNA ratio (w:w), and the final 
volume was adjusted to 1.05 mL. The siRNA final concentration was 5 µg/mL.  Effective 
diameter and zeta potential of polyplexes were determined by dynamic light scattering (DLS) 
using a Malvern Zetasizer Nano-ZS.  For the effective diameter, three measurements consisting 
of 10 runs of 10 s each were performed on each sample at room temperature.  For the zeta 
potential, three measurements consisting of 15 runs each were performed on each sample at 
room temperature.  The Smoluchowski model was applied to calculate the zeta potential.   
4.2.8 Confocal microscopy.  MDA-MB-231-luc+ cells (1 x 106 cells/plate) were seeded in 2 mL 
of growth medium (DMEM with 10% v/v FBS) in plates (60 mm x 15 mm) with 3 glass 
coverslips (12 mm diameter) 24 h prior to transfection and incubated at 37°C and 5% CO2.  
Immediately prior to transfection, polyplexes were formed as previously described.  siRNA (11.3 
µL of 20 µM stock solution) was combined with a specific volume of the polymer conjugates 
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stock solution to achieve the designated polymer:siRNA ratio (w:w), and the final volume 
adjusted to 310 µL.  After formation of the polyplex, 4.19 mL of serum-free medium was added 
to the polyplex solution.  The growth medium was removed from the plates, and cells were 
rinsed with 2 mL of 1x Dulbecco's phosphate buffered saline (DPBS, Cellgro, Mediatech Inc., 
Manassas VA).  The glass coverslips were transferred to new plates with 2 mL of serum-free 
medium (3 coverslips/plate), corresponding to 120,000 cells/plate.  The serum-free medium from 
the plates was replaced with 2.25 mL of the polyplex solution.  The siRNA concentration per 
plate was 0.67 µg/mL (1.5 µg siRNA per plate).    Plates were incubated at 37°C and 5% CO2 for 
4 h.  Cells were rinsed 3 times with DPBS, fixed with 3.7% formaldehyde in DPBS for 10 min 
followed by quenching with 10 mg/mL BSA in DPBS.  Coverslips were mounted in microscopy 
slides using Vectashield mounting medium (Vector Laboratories, Burlingame CA), and cells 
were immediately imaged using a Leica TCS SP2 laser scanning confocal system with a HCX 
PL APO 63x/1.32-0.6 oil immersion CS objective.  FA-containing polymer conjugates were 
detected by excitation at 488 nm with a 4-line argon laser, and fluorescence emission was 
collected at 500-550 nm.  
4.2.9 Cytotoxicity.  MDA-MB-231-luc+ (8,000 cells/well) were seeded in 100 µL of growth 
medium (DMEM with 10% v/v FBS) in clear 96-well plates 24 h prior to transfection and 
incubated at 37°C and 5% CO2.  A 0.5 mg/mL polymer stock solution was prepared with 10 mM 
HEPES buffer, pH 7.2 and sonicated for 60 s.  From this stock solution, polymer conjugates were 
diluted with 10mM HEPES buffer, pH 7.2 to various concentrations at a final volume of 120 µL 
and vortexed for 5 s. The growth medium was removed from the wells, and cells were rinsed 
with 150 µL of DPBS.  Serum-free medium (no phenol red, 120 µL) was added to the wells, 
followed by aliquots of polymer dilutions (30 µL).  The final polymer concentrations per well 
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were 0, 1, 2.5, 5, 7.5, 10, 15, 20, 30, 40, 60, 100 and 150 µg/mL.  Plates were incubated at 37°C 
and 5% CO2 for 4 h, after which the medium in each well was replaced with 150 µL of fresh 
growth medium (DMEM with 10% v/v FBS).  Plates were incubated at 37°C and 5% CO2 for an 
additional 44 h.  Cytotoxicity was assessed by the MTS Assay using CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (Promega, Madison WI) according to the manufacturer’s 
instructions.  Following incubation of the plates at 37°C and 5% CO2 for 2 h, the absorbance was 
obtained using a Molecular Devices SpectraMax Plus384 UV/Vis spectrophotometer at λabs = 490 
nm.  Data was fitted to sigmoidal (dose-response) curve using OriginPro 8, and IC50 values were 
calculated as the polymer concentration (in µg/mL) corresponding to 50% cell survival or half 
the absorbance measured at a polymer concentration of 0 µg/mL.  Each condition was performed 
in triplicate. 
4.2.10 siRNA transfection.  MDA-MB-231-luc+ (8,000 cells/well) were seeded in 100 µL of 
growth medium (DMEM with 10% v/v FBS) in both white and clear 96-well plates 24 h prior to 
transfection and incubated at 37°C and 5% CO2.  Immediately prior to transfection, polyplexes 
were formed as previously described.  The growth medium was removed from the wells, and 
cells were rinsed with 150 µL of DPBS.  Serum-free medium (no phenol red, 120 µL) was added 
to the wells, followed by aliquots of the polyplex solution (30 µL).  The siRNA concentration 
per well was varied from 0.33 µg/ml (50 ng of siRNA/well) to 3 µg/ml (450 ng of siRNA/well).  
Plates were incubated at 37°C and 5% CO2 for 4 h, after which the medium in each well was 
replaced with 150 µl of fresh growth medium (DMEM with 10% v/v FBS).  Plates were 
incubated at 37°C and 5% CO2 for an additional 44 h.   
 As a positive control, cells were transfected with PEIb, RNAiFECT (Qiagen) and 
TransIT-siQuest (Mirus Bio, Madison WI).  PEIb followed the same procedure as previously 
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described for polymer conjugates.  Transfections with RNAiFECT were performed according to 
the manufacturer's instructions with a siRNA:RNAiFECT (µg:µL) = 1:6 in Buffer EC-R 
supplied.  Transfections with TransIT-siQuest were performed according to the manufacturer's 
instructions with a siRNA:RNAiFECT (µg:µL) = 1:5 in Opti-MEM.  Aliquots of the polyplex 
solution (30 µl) were added to the cells in 120 µL of serum-free medium.  Plates were incubated 
at 37°C and 5% CO2 for 4 h, after which the medium in each well was replaced with 150 µL of 
fresh growth medium (DMEM with 10% v/v FBS).  Plates were incubated at 37°C and 5% CO2 
for an additional 44 h.   
 White 96-well plates were assayed for luciferase activity using Bright-Glo Luciferase 
Assay (Promega, Madison WI) according to the manufacturer’s instructions.  Clear 96-well 
plates were assayed for either total protein content using BCA Protein Quantification Assay 
(Thermo Scientific Pierce) according to the manufacturer’s instructions or relative cell viability 
by MTS assay as previously described.  Each polyplex/control condition was performed in 
triplicate for luciferase activity, total protein quantification and cell viability.   
4.2.11 Bright-glo luciferase assay.  Prior to luciferase activity quantification, growth medium 
was removed from the wells of the white 96-well plate, and cells were rinsed with 150 µl of 
DPBS.  Serum-free medium (no phenol red, 100 µL) was added to each well.  Bright-Glo 
working solution (Promega, Madison WI) (100 µL)  was added to each well followed by 2 min 
incubation at room temperature. Luminescence (in RLU units) was obtained with a Veritas 
Microplate Luminometer (Turner Biosystems). 
4.2.12 BCA protein quantification assay.  Prior to total protein quantification, growth medium 
was removed from the wells of the clear 96-well plate, and cells were rinsed with 150 µL of 
DPBS.  Glo-lysis buffer (Promega, Madison WI) (10 µL) was added to each well, and plates was 
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gently shaken at room temperature on a microplate shaker for 10 min.  BCA working solution 
(Thermo Scientific) (200 µL) was added to each well and incubated at 37°C and 5% CO2 for 1 h.  
Absorbance was obtained using a Molecular Devices SpectraMax Plus384 UV/Vis 
spectrophotometer at λabs = 562 nm.  The total protein (in µg per well) was calculated from a 
calibration curve generated from a BSA protein standard with concentrations varying from 0 to 
2000 µg/mL performed simultaneously with each experiment.  
4.2.13 Statistical analysis.  All data included are presented as the mean + standard deviation.  
Statistical analysis between samples was performed via a two-tailed unpaired t-test.  Difference 
between samples were considered significant if p < 0.05. 
 
4.3 Results 
4.3.1 Polymer conjugates. pAA was synthesized via  RAFT polymerization using 4,4-
azobis(cyanopentanoic acid) (A-CPA) and 4-cyanopentanoic acid dithiobenzoate (CPA-DB) as 
the radical initiator and chain transfer agent (CTA), respectively.  By varying the monomer to 
CTA molar ratio, pAA of four different Mn, specifically 2,900 kDa, 4,800 kDa, 10,400 kDa and 
20,900 kDa, were synthesized with PDIs ranging from 1.36 to 1.19 depending on the Mn.  The 
Mn range for pAA was selected based on the limited solubility of the polymer conjugates at 
physiological pH. 
 A library of polymers was synthesized by conjugating two distinct moieties, Gal and 
Agm, at different ratios to the side chains of pAA.  The conjugation of both moieties was 
mediated via an amidation reaction between the side chain carboxyl groups in pAA and the 
amino groups in these ligands using DMTMM as the condensing agent.  The conjugation of both 
ligands to pAA was achieved in a two-step reaction, where Agm was first introduced followed 
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by Gal (Figure 4.1).  Simultaneous conjugation of both ligands is possible; however, in order to 
achieve high Agm content (> 39%), a two-step conjugation reaction is more effective.  The 
degree of side chain substitution of each ligand was determined by 1H NMR (400MHz) 
spectroscopy with D2O as the solvent and is referred to as a percentage value.  The percentage 
reported (mol %) corresponds to the total ligand content relative to the total side chains (or 
repeating units) in each polymer.  To obtain different ligand content, the [COOH]0 to 
[DMTMM]0 molar ratio was varied while keeping [NH2]0 = 2·[DMTMM]0 and [pAA]0 = 3.0 
mg/mL.   
 Table 4.1 includes the polymer conjugates comprising the library with their 
corresponding Mn, PDI, Gal content and Agm content. A total of 22 polymers were evaluated; 
four Mn pAA, and six polymer conjugates (except for 21kDa-P polymers) per Mn pAA, each with 
a unique combination of Gal and Agm content.  21kDa-P polymers only have four Gal/Agm 
combinations (21-P1 to 21-P4) due to solubility issues at physiological conditions for 21-P5 and 
21-P6.    
4.3.2 Relative binding affinity.  Figure 4.2(A-D) shows the relative binding affinity for all 
polymer conjugates with siRNA at various polymer:siRNA ratios (w:w); (A) 3kDa-P, (B) 5kDa-
P, (C) 10kDa-P and (D) 21kDa-P.  The relative strength of electrostatic interactions between the 
polymer and siRNA can be measured by EtBr fluorescence quenching.  EtBr intercalates 
between the strands of nucleic acids generating a strong fluorescence.  Maintaining the siRNA 
concentration constant, as the polymer concentration in solution increases, its binding with 
siRNA excludes EtBr from interacting with the siRNA, thus generating a reduction in the 
detectable fluorescence.  This effect provides a quantitative analysis of the relative binding 
strength of the polymer conjugates with siRNA. 
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Figure 4.1: Synthesis schematic of polymer conjugates.  Polymers precursor (pAA) were 
synthesized by RAFT polymerization with different molecular weights, followed by a two-step 
conjugation of Agm and Gal at different mol percent (%) substitutions. 
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Table 4.1:  Polymer precursor (pAA) Mn and PDI, Agm content and Gal content for polymer 
conjugates 
Entry Name pAA Mna PDIa 
Agm Content 
(%)b 
Gal Content 
(%)b 
1 
3kDa-P 
3-P1 
2 900  1.36 
76 0 
2 3-P2 76 3 
3 3-P3 56 17 
4 3-P4 56 8 
5 3-P5 45 22 
6 3-P6 45 13 
7 
5kDa-P 
5-P1 
4 800 1.32 
76 0 
8 5-P2 76 2 
9 5-P3 55 17 
10 5-P4 55 10 
11 5-P5 46 28 
12 5-P6 46 14 
13 
10kDa-P 
10-P1 
10 400 1.19 
78 0 
14 10-P2 78 3 
15 10-P3 56 18 
16 10-P4 56 10 
17 10-P5 46 26 
18 10-P6 46 14 
19 
21kDa-P 
21-P1 
20 900 1.19 
72 0 
20 21-P2 72 3 
21 21-P3 55 12 
22 21-P4 55 4 
 
aAs determined by size exclusion chromatography.  bAs determined by 1H NMR (400MHz, D2O).  
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 From Figure 4.2(A-D) a trend directly correlated to the Agm and Gal contents can be 
distinguished for all polymers.  The higher the Agm content, the higher the cationic density in 
the polymer and the stronger the electrostatic interactions with the negatively charged siRNA.  
The Gal content in the polymer influences the total cationic density as well by blocking some of 
the free carboxyl groups in pAA which could have become ionized in solution imparting a 
negative charge to the polymer.  Therefore, keeping Agm content constant, the higher the Gal 
content the more effective the binding of the polymer with siRNA.   
 For all Mn  polymers, P1 and P2 were shown to be the most effective in condensing 
siRNA to at least 80% at a polymer:siRNA (w:w) = 5:1 or higher.  As the Agm content 
decreases, the ability to fully condense the siRNA lessens.  For instance, P3 and P4 are able to 
condense ~70% of the siRNA at a polymer:siRNA (w:w) > 20:1 for 3kDa-P and 5kDa-P, and at 
a polymer:siRNA (w:w) = 10:1 for 10kDa-P and 21kDa-P.  P5 is able to condense ~60% of the 
siRNA; however, to achieve this a polymer:siRNA (w:w) ratio of 40:1 or higher are required.  P6 
can also condense ~60% of the siRNA at a polymer:siRNA (w:w) = 40:1 for 10kDa-P, and ~40% 
of the siRNA at a polymer:siRNA (w:w) = 20:1 for 3kDa-P and 5kDa-P.   
 4.3.3 Heparin competitive displacement.  To evaluate the stability of the polyplex in the 
presence of other anionic compounds, a heparin competitive displacement assay was carried out.  
In this assay, the polyplex is exposed to different amounts of heparin, a highly anionic 
polysaccharide.  The heparin will compete with the siRNA for interactions with the polymer 
conjugate, thus displacing the siRNA from the polyplex.  This dissociation can be evaluated by 
quantifying the displaced siRNA in the solution by means of EtBr fluorescence.  A relative 
polyplex stability (RPS) is calculated from equation 4.1:  
RPS = siRNA hep
siRNA polyplex
F F
F F
−
−
          (4.1) 
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Figure 4.2: Relative binding affinity of polymer conjugates with siRNA as measured by 
ethidium bromide fluorescence quenching.  [siRNA] = 3 µg/mL.  N = 3.  Error bars represents 
standard deviation.  25kDa PEIb was included for comparison. (A) 3kDa-P; (B) 5kDa-P; (C) 
10kDa-P; (D) 21kDa-P.   
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where FsiRNA is the corrected fluorescence siRNA in the absence of the polymer vector, Fpolyplex is 
the corrected fluorescence of siRNA in the presence of the polymer vector and Fhep is the 
corrected fluorescence of siRNA in the presence of the polymer vector and heparin.  Figure 
4.3(A-C) shows relative fluorescence of EtBr after exposing the polyplex to varying amounts of 
sodium heparin.  For the 10kDa-P library as a representative example (Figure 4.3(A)), polymers 
with higher Agm content, particularly 10-P1 and 10-P2, provide a stronger resistance to 
interactions with competitive anionic species, as correlated to the stronger binding affinity with 
siRNA.  Taking 10-P2 as a representative example, as the polymer:siRNA (w:w) ratio increases, 
the strength of electrostatic binding between siRNA and the polymer is higher, thus higher 
amounts of heparin are needed to disrupt the siRNA-polymer complex (Figure 4.3(B)).  For 
instance heparin:siRNA (w:w) = 2.5:1 is required to disrupt a polymer:siRNA (w:w) = 5:1, while 
a heparin:siRNA (w:w) = 10:1 is required to disrupt a polymer:siRNA (w:w) = 10:1 and 
polymer:siRNA (w:w) = 20:1.  The polymer precursor Mn also has an impact on the competitive 
binding of heparin with cationic polymers.  It is evident from Figure 4.3(C) that lower Mn 
polymer conjugates provide higher polyplex stability in solution as it shows less siRNA 
displacement by competitive anionic species as compared to their higher Mn counterparts.  
4.3.4 Polyplex stability in serum.  The stability of the polyplexes in serum and the ability of the 
polymer conjugates to protect the siRNA from nuclease degradation was evaluated.  In this 
assay, polyplexes were incubated in 10% FBS for various times, following which the siRNA was 
dissociated from the polyplex, and its integrity was examined via gel electrophoresis.  Figure 4.4 
shows images of RNA polyacrylamide gels where each lane correspond to a different incubation 
time.  Naked siRNA was degraded within 2 h of incubation in 10% FBS (Figure 4.4A), while 
siRNA recovered  from polyplexes formed with  10-P2 and 10-P3  remained almost intact at 48 h  
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Figure 4.3: Relative polyplex stability.  Displacement of siRNA from polyplex by the 
competitive interaction of heparin with polymer conjugates was measured by ethidium bromide 
fluorescence quenching.  [siRNA] = 3 µg/mL.  N = 3.  Error bars represent standard deviation.  
(A) 10kDa-P library at polymer:siRNA (w:w) = 10:1: 10-P1 (dark gray), 10-P2 (vertical lines), 
10-P3 (white), 10-P4 (diamond), 10-P5 (black), 10-P6 (squares).  (B)10-P2 at various 
polymer:siRNA ratios (w:w): w:w = 5:1 (light gray), w:w = 10:1 (vertical lines) and w:w = 20:1 
(black). (C) P2 polymers at polymer:siRNA (w:w) = 10:1: 3-P2 (horizontal lines), 5-P2 (light 
gray), 10-P2 (vertical lines), 21-P2 (black). 
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and 16 h of incubation in 10% FBS, respectively (Figure 4.4(B-C)).  This suggests that the 
polymer conjugates are able to protect the siRNA from serum nuclease degradation.   
4.3.5 Effective diameter and zeta potential.  Figure 4.5A shows the effective diameter of 
polyplexes formed from the polymer conjugates and siRNA at a polymer:siRNA (w:w) = 10:1.  
For all Mn, a trend was distinguished where particle size increases as Agm content decreases.  
For 10kDa-P at a polymer:siRNA (w:w) = 10:1, the particle size ranges from 125 nm to 180 nm.  
Decreasing, as well as increasing, the Mn of the precursor showed a decrease in effective 
diameter reaching polyplex sizes of ~80 nm.  In addition, for 10-P2, increasing the 
polymer:siRNA (w:w) ratio to 20:1 decreases the particle size to ~90 nm (Figure 4.5B).  Similar 
trend is observed for other Mn polymers.   
 Figure 4.6A shows the zeta potential of polyplexes formed from the polymer conjugates 
and siRNA at a polymer:siRNA (w:w) = 10:1.  All polymers conjugates, except P6, exhibit 
positive zeta potentials ranging from 20-40 mV.  All P6 polymer conjugates showed a net 
negative zeta potential.  Taking 10-P2 as a representative example at varying polymer:siRNA 
(w:w) of 1:1, 2.5:1. 5:1, 10:1 and 20:1 (Figure 4.6B), polyplexes exhibit a net positive zeta 
potentials of similar values for all polymer:siRNA (w:w) ratios except for polymer:siRNA (w:w) 
= 1:1, which showed a negative zeta potential.   
4.3.6. Confocal microscopy Confocal microscopy imaging was performed  to visualize the 
internalization of polyplexes into cells.  Two FA-labeled polymer conjugates, 10-P2-FA and 10-
P3-FA, were selected as representative examples for this analysis. For both conditions, polyplex 
internalization was achieved as distinguished by the strong fluorescence emitted from the interior 
of the cell 4 h post-transfection (Figure 4.7).  Punctuated as well as diffused fluorescence was 
perceived in both samples.  
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Figure 4.4: Polyplex stability in serum.  siRNA integrity was evaluated by gel electrophoresis 
after incubation of polyplexes at 37 °C in 10% v/v FBS at various times.  siRNA bands were 
stained with SYBR green II RNA gel stain and visualized under a UV transilluminator.  Lane 1 
corresponds to a 10bp DNA ladder.  (A) naked siRNA; (B) polyplexes formed with 10-P2 and 
siRNA (w:w = 10:1); (C) polyplexes formed with 10-P3 and siRNA (w:w = 20:1). 
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Figure 4.5: Effective diameter (Z-ave, nm) of polyplexes formed from polymer conjugates and 
siRNA.  [siRNA] = 5 µg/ml.  Three measurements were performed on each sample.  Error bars 
represents standard deviation.  (A) All polymer conjugates at a polymer:siRNA (w:w) = 10:1: 
3kDa-P (horizantal lines), 5kDa-P (dark gray), 10kDa-P (vertical lines), 21kDa-P (black).  
(B)10-P2 at various polymer:siRNA ratios (w:w). 
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Figure 4.6: Zeta potential (mV) of polyplexes formed from polymer conjugates and siRNA.  
[siRNA] = 5 µg/mL.  Three measurements were performed on each sample.  Error bars 
represents standard deviation.  (A) All polymer conjugates at a polymer:siRNA (w:w) = 10:1: 
3kDa-P (horizantal lines), 5kDa-P (dark gray), 10kDa-P (vertical lines), 21kDa-P (black).  
(B)10-P2 at various polymer:siRNA ratios (w:w). 
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Figure 4.7: Confocal microscopy images of polyplexes internalized by MDA-MB-231-luc+ cells 
4 h post-transfection.  Cell were transfected with polyplexes formed from FA-labeled polymer 
conjugates and siRNA.  [siRNA] = 0.67 µg/mL (1.5 µg siRNA per plate).  (A) 10-P2-FA, 
polymer:siRNA (w:w) = 10:1; (B) 10-P3-FA, polymer:siRNA (w:w) = 20:1.   
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4.3.7 Cytotoxicity.  The cytotoxicity of free polymers conjugates was assessed by calculating the 
IC50 values or half maximal inhibitory concentration that refers to the polymer concentration 
needed to kill 50% of the cell population.  A sigmoidal fit was applied to the plot of 
log10(polymer concentration) vs. relative absorbance at 490 nm (MTS assay), and the polymer 
concentration was calculated at 50% cell survival. 
 Table 4.2 includes the IC50 values for all polymer conjugates.  Two trends are 
distinguished for these polymer conjugates: (1) the cytotoxicity decreases as Agm content 
decreases; (2) the cytotoxicity decreases as pAA Mn decreases.  Cytotoxicity was more 
prominent for P1 and P2 which had conserved IC50 values of ~5-6 µg/mL for all Mn polymers.  
Still, for all polymer conjugates, the cytotoxicity obtained was lower than for 25 kDa PEIb, 
which had an IC50 value of 2.9 µg/mL at the same conditions.        
4.3.8 siRNA transfection.  MDA-MB-231-luc+ cells (human breast carcinoma cell line) were 
transfected with siRNA targeting the luciferase protein.  Figure 4.8(A-D) shows the relative cell 
viability and relative luciferase expression 48 h after siRNA transfection mediated by the 
polymer conjugates.  Polyplexes were formed at various polymer:siRNA (w:w) ratios with a 
constant siRNA concentration of 0.33 µg/mL (50 ng/well).  Luciferase expression (RLU) was 
normalized with the total protein content as determined by the BCA total protein assay.  The 
relative cell viability after treating the cells with polyplexes was performed simultaneously.   
 A wide range of polymer:siRNA (w:w) ratios for each polymer conjugate was assessed to 
identify the optimal parameter that would achieve the highest transfection efficiency.  The w:w 
ratio was varied for each polymer according to their relative binding affinities with siRNA and 
IC50 values.  For all Mn, polymers with the highest Agm content, particularly P1, P2 and P3, 
achieved improved transfection efficiency than those with low Agm content,  leading to a lower 
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Table 4.2: IC50 values for polymer conjugates and 25kDa PEIb after 48 h incubation with MDA-
MB-231-luc cells+ (MTS assay).  N = 3.  
Entry Polymer IC50, free polymer 
1 3-P1 3kDapAA-76%A 6.5 + 0.2 
2 3-P2 3kDapAA-76%A-3%G 7.5 + 0.7 
3 3-P3 3kDapAA-56%A-17%G 55.7 +1.9 
4 3-P4 3kDapAA-56%A-8%G 121.9 + 2.5 
5 3-P5 3kDapAA-45%A-22%G > 150 
6 3-P6 3kDapAA-45%A-13%G > 150 
7 5-P1 5kDapAA-76%A 5.0 + 0.5 
8 5-P2 5kDapAA-76%A-2%G 5.2 + 0.7 
9 5-P3 5kDapAA-55%A-17%G 54.9 + 1.1 
10 5-P4 5kDapAA-55%A-10%G 48.8 + 1.2 
11 5-P5 5kDapAA-46%A-28%G > 150 
12 5-P6 5kDapAA-46%A-14%G > 150 
13 10-P1 10kDapAA-78%A 4.7 + 0.4 
14 10-P2 10kDapAA-78%A-3%G 5.9 + 0.4 
15 10-P3 10kDapAA-56%A-18%G 13.1 + 0.9 
16 10-P4 10kDapAA-56%A-10%G 20.2 + 1.0 
17 10-P5 10kDapAA-46%A-26%G > 150 
18 10-P6 10kDapAA-46%A-14%G > 150 
19 21-P1 10kDapAA-72%A 6.5 + 0.6 
20 21-P2 10kDapAA-72%A-3%G 5.4 + 0.5 
21 21-P3 10kDapAA-55%A-12%G 10.0 + 0.9 
22 21-P4 10kDapAA-55%A-4%G 15.3 + 0.6 
23 PEIb 25kDa 2.9 + 0.3 
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Figure 4.8: Relative cell viability and relative luciferase expression of MDA-MB-231-luc+ cells 
48 h post-transfection for all polymer conjugates at [siRNA] = 0.33 µg/mL (50 ng siRNA/well).  
N = 3.  Error bars represent standard deviation.  Conditions showing statistically significant 
protein knockdown (p < 0.05) as compared to nonspecific siRNA transfection carried out under 
the same conditions are indicated by an asterisks (*).  (A) 3kDa-P; (B) 5kDa-P; (C) 10kDa-P; 
and (D) 21kDa-P. 
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protein expression 48 h after treatment.   
 Although no detectable cytotoxicity was perceived for the 3kDa-P library at a constant 
siRNA concentration of 0.33 µg/mL, only a modest protein knockdown of ~40% was achieved 
with 3-P1 and 3-P2 at various polymer:siRNA (w:w) ratios.  However, these values are not 
considered statistically significant as compared to nonspecific siRNA transfection carried out 
under the same conditions.  In contrast, 5kDa-P and 10kDa-P libraries were both more successful 
at siRNA transfection and protein knockdown as compared to the 3kDa-P library, particularly for 
P1 and P2 polymers.  5-P1 and 5-P2 (w:w = 15:1) achieved ~60% knockdown while 10-P1 and 
10-P2 (w:w = 15:1) achieved ~70% knockdown, all being statistically significant as compared to 
nonspecific siRNA transfection carried out under the same conditions (p < 0.05).  In addition, for 
both libraries, P3 polymers (w:w = 30:1) achieve ~50% protein knockdown.  As the Agm 
content decreases, less significant varied results were obtained (~0-40% protein knockdown).  In 
the case of the 21kDa-P library, only 21-P1 and 21-P2 at w:w = 15:1 showed protein knockdown 
that was statistically significant as compared to nonspecific siRNA transfection carried out under 
the same conditions (p < 0.05).  Under these conditions, protein knockdown of ~ 56% was 
achieved with a relative cell viability > 70%.  
 Polymers that exhibited negligible cytotoxicity, though modest transfection efficiencies at 
siRNA concentration of 0.33 µg/mL, were further evaluated for protein knockdown at higher 
siRNA concentrations up to 3.0 µg/mL (Figure 4.9(A-D)).  These polymer conjugates include P3 
at w:w = 10:1 and w:w = 20:1, and P5 at w:w = 60:1.  For all conditions, increasing the siRNA 
concentration lead to a significant increase in protein knockdown.  P3 polymers at a w:w = 20:1 
were shown to be the most effective transfection reagents as revealed by the marked decrease in 
relative  luciferase  expression.  Particularly,  5-P3  at  w:w = 20:1  achieved up  to  84% protein  
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Figure 4.9: Relative cell viability and relative luciferase expression of MDA-MB-231-luc+ cells 
48 h post-transfection with varying siRNA concentration.  Polymers evaluated were P3 (w:w = 
10:1 and w:w = 20:1) and P5 (w:w = 60:1) polymers.  N = 3.  Error bars represent standard 
deviation.  Conditions showing statistically significant protein knockdown (p < 0.05) as 
compared to nonspecific siRNA transfection carried out under the same conditions are indicated 
by an asterisks (*).  (A) 3kDa-P; (B) 5kDa-P; (C) 10kDa-P; and (D) 21kDa-P. 
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knockdown with > 70% cell viability.  
 Transfection of siRNA with 25kDa PEIb, one of the most effective polymeric delivery 
vectors, and two commercially-available transfection reagents (RNAiFECT and TransIT-
siQuest) were included for comparison (Figure 4.10A).  Some of the conditions evaluated for our 
polymer conjugates achieved better outcomes than PEIb which could generate up to ~55% 
protein knockdown at [siRNA] = 0.33 µg/mL (w:w = 5:1) or [siRNA] = 0.66 µg/mL (w:w = 
2.5:1).  Higher siRNA concentrations or PEIb:siRNA (w:w) ratios to enhance protein 
knockdown is not viable due to the high cytotoxicity accompanied by PEIb.  For the 
commercially-available transfection reagents, at analogous conditions, protein knockdown of 
~60% and ~80% was achieved for RNAiFECT and TransIT-siQuest, respectively.  Nonspecific 
siRNA transfection carried out under the same conditions (for those considered statistically 
significant) are shown in Figure 4.10B.   
 
4.4 Discussion 
  The favorable transfection of siRNA into culture cells is reliant on multiple factors 
including the structural components of the polymeric vector and the polymer:siRNA weight 
ratio.  These features will alter both the biophysical and biochemical properties which will have a 
great influence on siRNA delivery efficiency.  Herein we have analyzed a library of polymers 
with a variety of structural elements including Mn of the polymer, side chain composition and 
side chain density.   
 One of the side chain functional groups incorporated into the design is Agm, which 
imparts a cationic density essential for electrostatic interactions between polymer chains and 
siRNA, and cellular membrane.  The guanidium groups from the Agm moieties are protonated at  
113 
 
         
 
 
      
Figure 4.10: Relative cell viability and relative luciferase expression of MDA-MB-231-luc+ 
cells 48 h post-transfection.  N = 3.  Error bars represent standard deviations.  (A) Commercially-
available transfection reagents; 25kDa PEIb (horizontal lines), RNAiFECT (black), TransIT-
siQuest (vertical lines), siRNA (3.0 µg/mL), nonspecific (NS) siRNA (3.0 µg/mL) and cells only 
(dark gray); (B) nonspecific siRNA transfection carried out with polymer conjugates under the 
same conditions. 
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physiological    conditions    providing   a strong electrostatic interaction with negatively charged 
phosphate groups along the siRNA backbone.  Moreover, Agm has been shown to promote 
cellular internalization due to interactions between the guanidium groups and the sulfate groups 
of the cell surface glycosaminoglycan20.  The number of guanidium groups in arginine-rich 
peptides have been found to significantly influence the translocation21,22.  Thus controlling the 
Agm content is critical for efficient interactions with the cell membrane while avoiding non-
specific targeting.  The second component incorporated into the design is Gal.  Carbohydrates 
can enhance transfection efficiencies and promote cell-specific targeting through lectins (sugar-
binding proteins) localized on cell membranes. For instance, lactosylated and galactosylated 
polymers have been shown to enhance nucleic acid delivery to hepatocytes both in vitro and in 
vivo23-28.  However, the degree of substitution of Gal into polymer vectors can have an impact on 
the polyplex size and transfection efficiency24.  Therefore, careful identification of optimal 
number of Gal residues in the polymer is crucial for effective siRNA delivery.  
 The library comprises of a total of 22 polymers; four Mn polymer precursors (3kDa, 
5kDa, 10kDa to 21kDa), each with varying combinations of Agm and Gal content.  The higher 
the Agm content in the polymer, the stronger electrostatic binding with siRNA and the higher 
polyplex stability in the presence of other anionic species; in addition to smaller effective particle 
diameters and higher net zeta potentials.  However, polymer conjugates with high Agm content 
generate higher cytotoxicity as identified by the low IC50 values (~5 µg/mL).  In contrast, 
polymers with the lowest amount of Agm (45%-46%) exhibited minimal cytotoxicity (IC50 > 150 
µg/mL); however these are not able to fully condense siRNA.  This may be due to the low 
amount of guanidium groups and the presence of both positive and negative charges in the 
polymer chain which may hinder the siRNA from effective interaction with the available positive 
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charges.  The Mn of the polymer precursor influences the biophysical properties of these vectors, 
particularly the stability in the presence of anionic species.  Lower Mn polymers appeared more 
stable in the presence of heparin than their higher Mn counterparts, possibly due to their more 
comparable chain length with siRNA.  Polycations and polyanions with charged segments of 
matched chain length have been found to undergo molecular recognition in solution forming 
assemblies of higher stability29.       
 The internalization of polyplexes was examination via confocal microscopy as this is 
effective technique to analyze siRNA delivery in cell culture30.  For 10-P2 and 10-P3 polymers, 
confocal images showed both punctuated and diffused fluorescence in the interior of the cell 4 h 
post-transfection.  The punctuated fluorescence corresponds to polyplexes localized in the 
endosome, while the diffused fluorescence corresponds to polyplexes in the cytosol.  This 
suggests that the polyplexes were able to successfully escape the endosomal compartment after 
cellular internalization by receptor-mediated endocytosis, one of the major intracellular barriers 
of siRNA delivery.    
 Although the lower Mn (3kDa-P) is inclined to be less cytotoxic and more stable in the 
presence of anionic species, these polymers are shown to be less efficient mediating siRNA 
transfection.  On the other hand, although high transfection efficiencies at some conditions, the 
higher Mn (21kDa-P) causes more prominent cytotoxicity effects.  Therefore, 5kDa-P and 
10kDa-P libraries are considered the most promising candidates for siRNA delivery, particularly 
P2 and P3 polymers.  Our most favorable condition was 5-P3 at a polymer:siRNA (w:w) = 20:1 
which showed a good balance between high transfection efficiency and low cytotoxicity.  The 
results for this polymer were superior to PEIb and comparable to TransIT-siQuest; however, a 
direct comparison with PEIb is more relevant since it is a polymer-based vector.   
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CHAPTER 5 
CLIMB GK-12: SUMMER PROGRAM AND INQUIRY-BASED CURRICULUM 
DEVELOPMENT 
 
5.1 Introduction 
 The Cornell Learning Initiative in Medicine and Bioengineering (CLIMB) GK-12 
program is a bridge between graduate students in the biomedical engineering field and 
high/middle school science teachers.  Through this program, science teachers were integrated in 
a six-week long summer research project with a graduate student.  In addition, an inquiry-based 
lesson plan was developed and implemented during the following academic year.  Through this 
program, I had the pleasure of working with Carolyn Wilczynski, a Biology Teacher at 
Binghamton High School (Binghamton NY).    
 The summer research was a collaborative effort between the partner teacher and the 
graduate fellow.  The research project focused on the internalization of  bioactive materials into 
cells, an important process in gene delivery.  Through fluorescently-labeling polymeric vectors, 
the uptake of polyplexes by culture cells was visualized via confocal laser scanning microscopy.  
Understanding these interactions and cellular internalization processes of biomaterials are of 
great relevance for gene therapy application, an important topic in biomedical engineering.   
 As part of the curriculum development, a more fundamental biology topic, specifically 
enzymes and chemical reactions, was approached as a need to bring novel activities into this 
substantial area.  This topic, covered in "The Living Environment Core Curriculum", is relevant 
to the New York State Learning Standards - Living Environment, particularly Standard 1 
(Analysis, Inquiry and design) and Standard 4  (physical setting and living environment) 
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(http://www.emsc.nysed.gov/ciai/).  The activity developed presented a simple inquiry-based 
exercise in which students learned about chemical reactions, enzyme activity and how different 
environmental factors can affect enzymatic reactions in biology.  The lesson plan, entitled 
"Enzymes and Their Functions", consisted of three main parts.  Part 1 was an introductory 
activity in which students correlated real locks and keys with enzymes and substrates to 
understand what enzymes are and how they work.  For Part 2, a standard experiment was carried 
out where enzyme action was investigated by quantifying the production of glucose by α-
amylase activity over starch using a spectrophotometer.  Part 3 was an inquiry-based lesson in 
which the students designed their own experiment based on enzyme activity.  The lesson plan 
developed was administered to high school students (9th grade) in the Bridges Program at 
Binghamton High School during 11 class periods of 45 min each.   Part 2 and Part 3 of the lesson 
plan are herein described.   
 
5.2 Summer research  
 Elucidating the internalization and intracellular trafficking pathways of polyplexes within 
cells will aid in the understanding of the mechanisms by which nucleic acids are delivered and 
utilized.  In our case, internalization of polyplexes into cells is facilitated by receptor-mediated 
endocytosis.  Once internalized, the polyplex is localized in the endosome compartment until 
escape into the cytosol is achieved.  An alternative to visualize and/or identify the intracellular 
destination of polyplexes in fixed or living cells is through fluorescent-labeling and confocal 
microscopy.  The goal of the summer research was to visualize the internalization of polyplexes 
formed from three distinct polymer conjugates and siRNA at various times post-transfection.  
The polymer conjugates were composed of poly(acrylic acid) (pAA) with various side chain 
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substitutions of two ligands, agmatine (Agm) and D-(+)-galactosamine (Gal).  The ligands and 
polymer structures, and ligands percent (%) substitution are shown in Figure 5.1. The 
information collected was intended to aid in the design of polymeric vectors for siRNA delivery.   
 Polymer conjugates were fluorescently labeled with fluoresceinamine.  From these 
polymer conjugates, polyplex were formed with siRNA at a polymer:siRNA (w:w) ratio of 5:1.  
24 h prior to transfection, HepG2/C3A cells were seeded in three glass disks (12 mm diameter) 
in microscopy plates (60 mm diameter) at a cell density of 1 x 106 cells/mL and incubated at 
37°C with 5% CO2.  Cells were treated with the fluorescently-labeled polyplexes and Alexa546 
transferrin (endosome marker) and incubated at 37°C with 5% CO2.  Cells were fixed with 3.7% 
formaldehyde at the designated times (2 h, 3 h and 4 h) and imaged using a Leica TCS SP2 laser 
scanning confocal system with a HCX PL APO 63x/1.32-0.6 oil immersion CS objective.  A 
sequential imaging procedure was applied. 
 Figure 5.2(A-L) showed the confocal images for Polymer 1 (Figure 5.2(A-D)), Polymer 2 
(Figure 5.2(E-H)) and Polymer 3 (Figure 5.2(I-L)) at times 2 h, 3 h and 4 h post-transfection.  
Both Polymer 1 (pAA-78%Agm) and Polymer 2 (pAA-78%Agm-3%Gal) were readily 
internalized by cells at 2 h post-transfection, independently of the presence or absence of Gal in 
the polymer.  However, Polymer 3 (pAA-32%Agm-55%Gal), corresponding to low Agm and 
high Gal contents, did not show any significant uptake even at 4 h post-transfection as perceived 
by the low fluorescence emitted inside the cell.  These results indicate that Agm, a highly 
cationic species, has a greater influence on cellular uptake than Gal.  Gal, although expected to 
enhance cellular internalization through interactions with the asialoglycoprotein receptors in the 
cell surface of hepatocytes, did not show any significant contribution for internalization into 
HepG2/C3A cells.  
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Figure 5.1:  (A) Agm and Gal structures, and degree of side chain substitution (%) in pAA.  (B) 
Polymer conjugates structure.  
 
 
 
 
 
  Polymer 1 Polymer 2 Polymer 3 
Name Structure Substitution (%) 
Agmatine  
(Agm)  
78 78 32 
D-(+)-Galactosamine 
(Gal) 
 
0 3 55 
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Figure 5.2.  Confocal microscopy images.  Polymer were labeled with fluoresceinamine (green) 
and endosomes were stained with Alexa546-transferrin (red).  Yellow areas (images D, H and L) 
show colocalization of polyplexes with endosomes.  Polymer 1 (pAA-78%Agm) at 2 h  (A), 3 h 
(B) and 4 h (C-D) post-transfection.  Polymer 2 (pAA-78%Agm-3%Gal) at 2 h (E), 3 h (F) and 4 
h (G-H) post-transfection.  Polymer 3 (pAA-32%Agm-55%Gal) at 2 h (I), 3 h (J) and 4 h (K-L) 
post-transfection.   
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5.3 Inquiry-based curriculum development: Enzyme action in biology - breaking starch 
down into glucose.    
5.3.1  Introduction.  Enzymes are biological catalysts that are essential components in many 
biochemical processes.  In biological systems, enzymes assist the breakdown and synthesis of 
multiple compounds by affecting the rate of a chemical reaction with a particular substrate. 
Enzymes are needed to digest food, produce energy, remove toxins from the bloodstream, to 
name a few processes, and are ubiquitous in every biological function. Therefore, it is important 
for students to understand the concept of enzymes and how they function, as well as how enzyme 
activity can be affected by different environmental factors (e.g. temperature, pH and 
enzyme/substrate concentration).  Enzymes and chemical reactions involved in cell function are 
important topics in Biology curricula, as acknowledged by The National Science Education 
Standards, Science Content Standard - The Cell.1 
 In this inquiry-based lesson, students design an experiment that will allow them to 
visualize the effect of environmental factors on enzyme activity. This sort of inquiry-based 
learning encourages students to develop a deep understanding of a scientific topic by challenging 
them to generate their own questions and propose a means by which to find a solution2-4.  
Particularly in this laboratory activity, students study how the enzyme α-amylase acts upon its 
starch substrate.  Amylase converts polysaccharides (long chains of sugars) into 
monosaccharides (single sugar molecules).  In the case of starch, α-amylase will break down 
starch into glucose as illustrated in Figure 5.3.  This important reaction takes place in the human 
digestive system where starch, which is a significant part of our diet, is broken down in smaller, 
assimilable sugars. 
 
126 
 
 
 
 
 
 
 
 
 
Figure 5.3: Breakdown of starch into glucose by α-amylase. 
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 When α-amylase and starch are mixed, the α-amylase begins to breakdown the starch into 
glucose.  If this reaction takes place inside a dialysis tube, a semi-permeable membrane, the 
glucose produced from the α-amylase/starch reaction will diffuse out of  the dialysis tube since it 
is small enough to pass through the pores of the membrane.  However, the α-amylase and the 
starch will remain inside the dialysis tube because these molecules are too large to diffuse out 
(Figure 5.4).  Students can quantify the amount of glucose present outside the dialysis tube over 
a period of time, to learn about the rate of enzyme activity.  Moreover, once a standard 
experiment is established, they can investigate how real biological processes can be regulated by 
specific environmental factors (e.g. temperature, pH, and enzyme/substrate concentration) and 
how these factors affect the enzyme activity and the resulting rate of  its action. 
 The presence of glucose can be qualitatively observed by the formation of a red 
precipitate following the addition of Benedicts solution5.  Furthermore, quantitative 
measurements of the glucose concentration using Benedict's solution can be achieved using 
spectrophotometry.  This technique is a simple and practical way to determine the amount of 
glucose produced from the α-amylase/starch reaction.  
 In this lab, students will: (1) understand the concept of enzymes, substrates, and chemical 
reactions; (2) quantify the amount of glucose produced from an α-amylase/starch reaction over 
time; (3) develop an experiment based on an environmental factor that affects enzyme activity 
(inquiry-based lesson).  This  laboratory activity is suited for high school biology students, 
including students with special needs, general education students, as well as those in advanced 
courses. Further information on this lesson and additional materials, including student's activity 
sheets, can be found through the Cornell’s Learning Initiative in Medicine and Bioengineering 
(CLIMB) website (http://climb.bme.cornell.edu/).  
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Figure 5.4: Schematic representation of glucose diffusion through a dialysis tube. 
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time (minutes) starch 
+ 
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+ 
glucose 
glucose 
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+ 
amylase 
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5.3.2 Materials and methods.  Reagents and equipment can be obtained from Carolina 
(Burlington NC) or Fisher Scientific.  List of materials can be found in Figure 5.5. 
5.3.2.1 Pre-laboratory: glucose calibration curve.  A calibration curve of glucose 
concentration with absorbance is needed to quantify the amount of glucose produced by the α-
amylase/starch reaction.  In the laboratory activity, students will measure the absorbance of a 
glucose/Benedict's solution with an unknown amount of glucose.  The value obtained will be 
correlated with one from the calibration curve to determine the amount of glucose in the 
unknown sample.   
 The calibration curve is prepared by utilizing several different solutions of known 
concentrations of glucose with a fixed amount of Benedict’s solution.  The absorbance of each 
sample is detected using a spectrophotometer, and a plot of absorbance (y-axis) vs. glucose 
concentration (x-axis) is generated (Figure 5.6).  A linear regression of this data will provide a 
slope (m) and a y-intercept (b) value according to equation 5.1:  
y = (m · x) + b   (5.1) 
 A general calibration curve should be generated by the teacher/instructor prior to the 
experiment.  If time is a constraint, our generated values of m = 1 and b = 0.6 can be used; 
however, it is highly recommended that a unique calibration curve is prepared, since the results 
can vary depending on the Benedict’s solution used.  This procedure for generating the 
calibration curve is based on ones used in undergraduate Cell Biology laboratories6.  
1. Place 500 mL of water in a 600 mL beaker (hot water bath), stir and heat to ~80 °C using a 
heating/stir plate and magnetic stir bar.  Do not allow water to boil. 
2. Prepare a 1 mg/mL glucose solution by dissolving 10 mg of glucose with 10 mL of water. 
3. Label 7 Eppendorf tubes (2 mL) with numbers from 1 to 7.  To each tube add the specified 
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Figure 5.5: List of equipments and materials for pre-lab (glucose calibration curve) and lab. 
 
 
 
 
 
Equipment: 
 Spectrophotometer 
 Small centrifuge 
 vortexer 
 
Materials for Pre-lab (Glucose 
Calibration Curve): 
 Benedict’s solution  
 Tap water 
 Glucose or dextrose (2 mg) 
 600 ml Beaker 
 Micropipettor (P1000) 
 Micropipette tips, 1 ml 
 Eppendorf tubes, 2 ml (7) 
 Floating Eppendorf tube holder 
 Tube holder 
 Plastic cuvettes (7) 
 Cuvette holder 
 Waste container 
 Timer 
 Stir/heating plate 
 Safety goggles 
 Gloves 
 
 
 
Materials for Lab (per group of students): 
 Benedict’s solution 
 Tap water 
 Starch (3 g, pre-weighed) 
 α-amylase (1 g, pre-weighed) 
 600 ml Beaker (2)  
 Dialysis tubing, 15 cm (~ 3cm width, 
molecular weight cutoff of 12,000 to 14,000 
MW)  
 Micropipettor (P1000) 
 Micropipette tips, 1 ml 
 Transfer pipettes (2) 
 Eppendorf tubes, 2 ml (7) 
 Floating Eppendorf tube holder 
 Tube holder 
 Plastic cuvettes (7) 
 Cuvette holder 
 Waste container 
 Magnetic stir bar, 3.5-5 cm 
 Dialysis clips (2) 
 Timer 
 Stir plate 
 Stir/heating plate 
 Safety goggles 
 Gloves 
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Figure 5.6: Representative plot of glucose concentration with absorbance (calibration curve). 
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amounts of the solutions listed in Table 5.1.  Mix each solution for 5 s. 
4. Insert all the tubes in a floating Eppendorf tube holder, and place the tube holder in the hot 
water for 10 min. 
5. Remove the tubes from the hot water and allow them to cool down to room temperature (~3 
min).  Centrifuge the tubes at ~6,600 rpm for 3 min. 
6. Without disturbing the precipitate in the sample tube, use a micropipettor to remove 1 mL of 
the liquid and place it in a plastic cuvette labeled with the same number.  
7. Set the spectrophotometer wavelength to 735 nm.  Use cuvette 7 (only water) to set a 
reference for the spectrophotometer.  Obtain the absorbance of each sample (cuvettes 1 to 6). 
8. Plot glucose concentration (x-axis) vs. absorbance (y-axis).  Perform a linear regression and 
obtain a slope (m) and a y-intercept (b) value according to Equation 5.1.   
5.3.2.2 Standard enzyme reaction.  The following procedure includes directions on how to 
collect and analyze data for the standard α-amylase/starch experiment.  The standard experiment 
is carried out at room temperature in water (pH ~ 7) with fixed amounts of starch (3 g) and α-
amlylase (1 g).  Each group of students should prepare their own standard experiment for 
comparison with the subsequent inquiry-based lesson, where the effect of environmental factors 
on enzyme activity is examined.     
Collecting Data 
1. Select the times at which samples will be collected.  Recommended times are 0, 5, 10, 15, 20 
and 30 min.  Label 7 Eppendorf tubes with numbers from 1 to 7, each corresponding to a 
time point plus a control.  
2. Place 500 mL of water in a 600 mL beaker.  From this beaker, remove 1.5 mL of water and 
transfer to Tube 1 (time = 0 min). 
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Table 5.1:  Volumes (mL) to be added in each tube for calibration curve of glucose 
concentration with absorbance.    
 
 
 
 
 
 
 
 
 
 
 
Tube 
# 
Glucose stock solution, 
1 mg/mL (mL) Water (mL) 
Benedict’s 
solution (mL) 
Final glucose 
concentration (mg/mL) 
1 0 1.50 0.3 0.00 
2 0.075 1.425 0.3 0.05 
3 0.15 1.35 0.3 0.10 
4 0.25 1.25 0.3 0.17 
5 0.5 1.0 0.3 0.33 
6 0.75 0.75 0.3 0.50 
7 0 1.80 0 0.00 
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3. Prepare the starch and amylase solutions: 
a. Dissolve 3 g of starch with 5 mL of water.  Mix the starch solution. 
b. Dissolve 1 g of amylase with 5 mL of water.  Mix the amylase solution. 
4. Seal the bottom of the dialysis tubing by wrapping one of the ends around a stir bar and 
clipping this end with a dialysis clip.  
5. Use a transfer pipette to add all of the starch solution into the dialysis tubing.  Use another 
transfer pipette to add all of the amylase solution into the dialysis tubing.  Clip the other end 
(top part) of the dialysis tubing with a dialysis clip. 
6. Insert the sealed dialysis tubing in the beaker with water and start the timer.  Set the stir dial 
in the stir plate to the lowest setting.   
7. Remove 1.5 mL of the water from the beaker and place it in a 2 mL labeled Eppendorf tube 
at each specified time (Tubes 2 through 6). 
Analyzing the Data 
 The concentration of glucose is determined in the manner previously described to 
generate the glucose calibration curve (Pre-Laboratory).  Add 0.3 mL of Benedict’s solution to 
each Eppendorf tube labeled 1 through 6.  Do not add Benedict’s solution to Tube 7, the control.  
Tube 7 will contain only water.  Thoroughly mix all tubes (1-7) and then place them in a hot 
water bath for 10 min.  Afterwards, the tubes should be centrifuged for 3 min.  Place 1 mL of the 
supernatant from each sample in plastic cuvettes that are numbered similarly to the Eppendorf 
tubes, and measure the absorbance at 735 nm.  Calculate the glucose concentration for each time 
point sample using the ‘m’ and ‘b’ values from the glucose calibration curve (Pre-laboratory).  
Use Equation 2 to calculate the glucose concentration, and plot glucose concentration (y-axis) vs. 
time (x-axis). 
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Glucose Concentration = y b
m
−  (5.2) 
 Glucose will diffuse out the membrane as α-amylase breaks down starch inside the 
dialysis tube.  The glucose concentration will increase over time until all of the starch is 
converted to glucose.  Thus, for the plot of glucose concentration vs. time, an increasing linear 
trend is expected (Figure 5.7).  A small inaccuracy is expected due to the time it takes glucose 
diffuse out the dialysis tubing; however, constant low-stirring of the dialysis tubing should 
minimize this error due to an increase in diffusion rate. 
5.3.2.3 Inquiry-based activity.  Students can design their own experiment to explore and 
understand how different factors affect enzyme activity after they have performed the standard 
experiment and are comfortable with measuring glucose concentration and working with the 
equipment/reagents. This experimental design should include: a statement of the problem, a 
hypothesis and an experimental procedure.  Following the experimental design, students should 
be allowed to: set up the experiment, record data, analyze results and draw a conclusion.  
 Examples of factors to be evaluated can be: temperature (higher or lower), pH (acidic or 
basic), or varying enzyme/substrate concentration.  The materials provided to students will 
depend on their specific experimental design.  Common materials are those used in the standard 
experiment. Additional materials that may be needed could include pH meter, hydrogen chloride 
(HCl) solution, sodium hydroxide (NaOH) solution, and ice.  A representative example for an 
experiment conducted at a higher temperature (48 °C) is illustrated in Figure 5.8.  
 After the inquiry exercise,    students and teachers can discuss what happens in biological 
systems when environmental factors change, such as what happens to digestive enzymes when 
acid reflux occurs, or muscle enzymes as we exercise, and enzyme deficiency problems such as 
lactase (lactose intolerance). 
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Figure 5.7: Representative plot of glucose concentration vs. time.  
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Figure 5.8: Representative plot of glucose concentration vs. time at a higher temperature (48°C). 
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5.3.3 Additional information 
Suggested question for students 
1. What trend for glucose concentration with the independent variable was observed in your 
data? 
2. Compared to the standard experiment, what effect did the experimental factor selected have 
on enzyme activity (i.e. higher or lower reaction rate)? 
3. Write a conclusion for this experiment (include whether your results support or refute your 
hypothesis). 
4. What are some possible sources of error? 
5. Ideas for future experiments? 
Additional Notes to Teachers 
Note 1: The α-amylase will form a light brown layer on the top of the dialysis tube, while the 
starch will form a white layer on the bottom.  The brown layer (α-amylase) will become larger 
over the course of the experiment, while the white layer (starch) will become smaller.  This can 
be pointed out as a qualitative observation of the α-amylase/starch reaction, and can be used as a 
demonstration of enzyme action for younger children who are not able to carry out the entire 
experiment.  
Note 2: A negative control experiment can be performed in which only starch and Benedict’s 
solution are placed in the dialysis tube (no α-amylase).  Students should predict that glucose will 
not be found in the outer side of the membrane after 30 min.   
5.3.4 Content assessment.  A content assessment was performed through a pre- and post-test to 
evaluate the gain in knowledge of the material.  A pre-test was administered before the lab to 
provide a measure of current knowledge and  a post-test (identical to the pre-test)  given after the  
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lab experience.  Results between the two sets were compared.  
 Pre-test was given three days before conducting the lab.  14 students completed the pre 
and post-test.  Pre and post-test were identical and consisted of 10 questions (8 multiple choice 
and 2 open questions).  Figure 5.9 includes the individual scores for the pre- and post-test 
(Figures 5.9A) and the relative score increase for the post-test (Figure 5.9B).  The overall score 
for the pre- and post-test were 27.9% and 40.4%, respectively, corresponding to a 12.5 score 
increase (44.8% of the pre-test score). 
5.3.5 Attitude assessment.  The questionnaire in Table 5.2 was given to the students as part of 
the post-test.  Pre-test included Question 8 – 11 but did not reveal any change in attitude.  A total 
of 11 students completed the questionnaire.  The score is an average of answers based on: 
5=strongly agree, 4=agree, 3=neutral, 2=disagree and 1=strongly disagree.  Open questions were 
also included as part of the questionnaire.  Some of the answers for the open questions section 
are included in Table 5.3. 
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Figure 5.9: (A) Individual scores for pre-test (horizontal lines) and post-test (gray bars). (B) 
Score increase for post-test relative to pre-test.   
 
 
 
 
 
 
 
 
 
 
141 
 
 
 
 
Table 5.2:  Attitude assessment questionnaire and overall scores  
 
 
 
 
 
 
 
 
 
Attitude assessment questionnaire Overall score 
1. I enjoyed the enzyme lab. 4.0 + 1.0 
2. The enzyme lab was more difficult than most science labs. 2.6 + 1.1 
3. The lock-and-key activity helped me understand better what enzymes 
are. 
3.6 + 0.9 
4. I enjoyed designing my own experiment about enzymes. 4.1 + 1.0 
5. I worked well with my teammate. 4.2 + 1.1 
6. I feel more comfortable designing research experiments than before. 3.6  + 1.0 
7. I enjoyed the enzyme lab more than most science labs. 3.1 + 1.2 
8. I enjoy science lessons. 3.5 + 1.1 
9. I enjoy science more than other school subjects. 2.7 + 0.6 
10. I prefer to understand something by doing an experiment rather than 
just reading about it. 
3.9 + 1.2 
11. Science is more difficult than other school subject. 3.2 + 1.0 
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Table 5.3: Selected answers from students from open questions in attitude assessment 
questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
What I liked most about this lab: What I did not like about this lab was: 
 Being able to do my own lab (4 students) 
 Making my own lab was cool 
 Making my own lab and using the pipettors 
 The key and lock (2 students) 
 Not being rushed to do the experiments 
 All the writing and the test 
 It wasn’t the best subject 
 All the writing was boring 
 The lock and key part 
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS  
 
Combinatorial chemistry can be an useful tool for the development of polymers as non-
viral delivery systems, as it offers great flexibility and the advantage of simultaneous analyses of 
a wide chemical and structural parameter range.  Mapping the structure-function parameter space 
through polymer libraries is valuable to understand the mechanisms of siRNA delivery 
potentially leading to safer and more efficient delivery systems.  In this work, we developed 
polymer libraries for the rational design of non-viral delivery systems.  Characterization of these 
vectors allows the identification of optimal structural properties for efficient transport and 
delivery of siRNA into cells.   
The development of siRNA delivery systems entails an iterative process for the design 
optimization of these vectors.  A series of steps were carried out for the development of these 
vectors, which includes: (1) synthesis of polymer precursors, (2) synthesis of polymer libraries, 
(3) in vitro biophysical and cellular characterization of polymer/siRNA complexes, and (4) 
correlation of polymer structure to siRNA delivery.  Depending on the outcome, either in vivo 
characterization is completed or re-optimization of the original design is performed (Figure 6.1).     
We employed RAFT polymerization to synthesize poly(methacrylic acid) (pMAA) and 
poly(acrylic acid) (pAA) with different molecular weights (Mn) up to 113,900 and 55,200 
respectively.  The selected I/CTA system, resulted in an effective method that, for these 
particular monomers, produced well controlled polymerizations under specific conditions.  
Various synthesis conditions including solvent, initial monomer concentration and pH were 
evaluated,  and a kinetic  analysis was  performed with  several  variations on  the initial  reactant           
145 
 
 
 
 
 
 
Figure 6.1: Iterative process for the design and development of polymer vectors for siRNA 
delivery. 
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ratios for MAA RAFT polymerizations.  It was determined that methanol is a more suitable 
solvent for the polymerization due to higher stability of the reactants and good control 
throughout the polymerization under the conditions analyzed.  Based on the results obtained for 
pMAA, pAA was synthesized in an analogous fashion using methanol as a solvent of choice.  
Both of these polymers were evaluated as precursors for the development of polymer libraries.  
Combinatorial libraries are a practical approach to investigate the structure-function 
relationships of polymeric biomaterials.  In particular, branched polymers with reactive side 
chain groups are an alternative for polymer precursors due to multiple sites available for 
modifications with different functional groups.  With this in mind, our goal was to fully evaluate 
the single and binary substitution of two distinct amine-containing ligands, D-(+)-galactosamine 
(Gal) and agmatine (Agm), to the side chains of pMAA and pAA by using DMTMM as a 
condensing agent.  The conjugation efficiency of these moieties was found to be influenced by 
the media pH, polymer concentration and ligands/polymer structures.  Under comparable 
conditions, the substitution of both ligands in pAA was significantly higher than in pMAA, 
reaching close to a two-fold increase in conjugation efficiencies, presumably due to the absence 
of a hydrophobic α-methyl group that generated solution conformation issues in the pMAA 
reactions.  In addition, Agm surpassed Gal total content in both polymers.  Nevertheless, total 
Gal and Agm content in pMAA reached 23% and 53%, while total Gal and Agm content in pAA 
reached 56% and 78%, respectively.   
Due to the anionic density at physiological conditions from the carboxyl groups in the 
polymer, a minimum amount of Agm moieties are required to impart a net positive charge to the 
polymer chains, this being more than half of the available carboxyl groups present.  A net 
cationic charge is required to allow electrostatic interactions with negatively charged siRNA.  
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The low degree of substitution of Agm in pMAA, proved that these polymer conjugates were not 
suitable as transfection reagents due to the poor binding affinity to siRNA (data not shown).  
Therefore, pAA was selected as a precursor to generate polymer libraries that were evaluated as 
non-viral delivery vectors.  pAA with four distinct Mn, 3 kDa (PDI = 1.36), 5 kDa (PDI = 1.32), 
10 kDa (PDI = 1.19) and 21 kDa (PDI = 1.19), were synthesized.  To the side chains of these 
polymer precursors, various combinations of Agm and Gal were substituted.  A total of 22 
polymers were evaluated with Agm varying from 78% to 46% and Gal contents as high as 26%.  
(For abbreviations and compositions of polymer conjugates refer to Table 4.1). 
The biophysical and cellular characterization of these polymeric vectors revealed 
interesting correlations pertaining to their efficacy as siRNA delivery systems.  In general for 
these polymers conjugates, the higher the Agm content, the more compact and stable polyplexes 
were formed and the higher transfection efficiency, but also the higher cytotoxicity.  As for the 
effect of molecular weight, the lower the polymer Mn, the more compact and stable polyplexes 
were formed and the lower cytotoxicity, but also the lower transfection efficiency.  Therefore, a 
critical balance between the polymer Mn and ligands substitution must be attained to optimize the 
transfection efficiency while maintaining high cell viability in culture.  Based on these criteria, 
the most favorable Mn identified were 5 kDa and 10 kDa.  From these libraries, P2 and P3 
polymers were the most effective, particularly 5-P3 which corresponds to a 5 kDa pAA with a 
side chain composition of 55% Agm and 17% Gal.   
 In future work, the efficacy of the selected vectors will be evaluated for siRNA delivery 
in vivo, specifically targeting Factor VII protein in mice.  Factor VII is a glycoprotein involved in 
coagulation cascades that is synthesized in the liver but circulates in an inactive form in the 
bloodstream.  Therefore, in vivo delivery targeted to the liver will be carried out, and the 
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transfection efficiency of the polymer conjugates will be evaluated by quantifying the expression 
of Factor VII protein at various times after intravenous injection (i.v.) of polyplexes.  In addition, 
to increase the stability of the polymer vector and avoid non-specific interactions with serum 
proteins, polyethylene glycol (PEG, 5,000 Da) will be incorporated through a maleimide-thiol 
linkage at the polymer conjugate end-group (Appendix II).  PEGylated polymer conjugates will 
also be evaluated for siRNA delivery in vivo.  Preliminary data on in vivo siRNA delivery is 
included in Appendix III.         
From the initial library generated, specific structural parameters that achieved favorable 
outcomes (high transfection efficiency with low cytotoxicity) were identified.  To further 
optimize the design of these vectors for enhanced siRNA delivery, additional structural 
modifications can be considered.  For instance, higher polyplex stability may be accomplished 
by introducing a reversible disulfide linkage between the siRNA and polymer conjugate.  
Cytotoxicity might be reduced by generating degradable copolymers from two low Mn polymer 
conjugates, since these have shown to be less cytotoxic than their higher Mn counterparts.  It is 
possible that some of these polymer conjugates are not able to efficiently escape the endosomal 
compartment, which can lead to lower transfection efficiencies.  Therefore, additional pH-
responsive moieties could be incorporated to overcome this intracellular barrier. 
  In summary, we developed polymer libraries that consist of structurally different but 
related cationic polymeric vectors, examined their biophysical properties and evaluated their 
ability to deliver siRNA to cells in vitro.  A tight control over their molecular structure is vital in 
order to achieve favorable outcomes.  The approach developed allowed the identification of 
potential candidates that could serve as siRNA delivery systems and provided a foundation upon 
which larger polymer libraries and more effective delivery vectors can be generated. 
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APPENDIX I 
ACRYLIC ACID UNDERGOES PARTIAL METHYLATION DURING RAFT 
POLYMERIZATION IN METHANOL 
 
AI.1 Introduction 
 RAFT polymerizations1,2 have proven to be extremely successful for the direct 
polymerization of many acidic monomers including acrylic acid (AA).  RAFT polymerization 
of AA has been carried out in many solvents including dimethylformamide, ethanol, 2-
propanol, dioxane, methanol and water1,3,4,5.  However, the solvent employed for such 
polymerizations can ultimately affect the end product.   
 Upon characterization of poly(acrylic acid) (pAA) synthesized by RAFT polymerization 
in methanol, we identified partial methylation (~6%) of the carboxyl side chains in pAA.  
Hydrolysis of the esters to obtain AA homopolymers was achieved by post-polymerization 
treatment with sodium hydroxide (NaOH). 
 
AI.2 Materials and methods 
AI.2.1 Materials.  Acrylic acid (99%), 4,4’-azobis(4-cyanopentanoic acid) (98.0%, Fluka) and 
1,4-dioxane, anhydrous (99.8%) were purchased from Sigma-Aldrich.  N-ethylmaleimide 
(99+%) was purchased from Alfa Aesar.  Tris(2-carboxyethyl) phosphine hydrochloride 
(TCEP·HCl) was purchased from Fisher Scientific.  HEPES buffer saline (HBS, 10 mM 
HEPES, 150 mM NaCl, pH 7.2) was prepared with ultrapure water and filtered through a 0.2 
µm PES membrane.  All other chemicals were purchased from Fisher Scientific at the highest 
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purity available.  CPA-DB was synthesized as previously described6.  Prior to the experiment, 
all solvents were purged under nitrogen for at least 10 min.   
AI.2.2 AA RAFT polymerization in methanol. In a 5 mL glass ampule equipped with a 
magnetic stirbar, AA (0.6 mL, 8.8 mmol) and CPA-DB (16.5 mg, 0.059 mmol; in 1.6 mL 
methanol) were transferred and purged under nitrogen for 5 min.  A-CPA (4.2 mg, 0.015 mmol; 
in 0.73 mL methanol) was added, and the solution was purged under nitrogen for 2 additional 
min.  The ampule was flame-sealed and inserted in a 60 °C oil bath under continuous stirring.  
The reaction was stopped at the designated time by inserting the ampule in an ice bath and 
exposing the solution to air.  The product was either directly purified or treated with NaOH for 
hydrolysis of side chains.  To purify the product, the solution was placed under vacuum for 10 
min to remove ~50% of the methanol, diluted with deionized-water and dialyzed using 
Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa or 1kDa MWCO) against deionized-
water for 3 days.  The product was recovered by lyophilization for 24 h.   
AI.2.3 Post-polymerization hydrolysis of side chains.  Immediately after the polymerization, 
a 0.1 mL aliquot of the polymer solution was mixed with 0.2 mL of NaOH (3N, 5N or 10N; 
NaOH:methanol (v/v) = 2:1).  The reaction was stirred at room temperature under nitrogen for 
2.5 h.  The solution was neutralized with formic acid, 88% and purified by dialysis using 
Spectra/Por regenerated cellulose dialysis tubing (3.5 kDa MWCO) against deionized-water for 
3 days and lyophilized for 24 h. 
AI.2.4 Disulfide reduction by TCEP. Reduction of disulfide bonds between polymer end-
groups was modified from previously established protocols7.  Briefly, pAA (30 mg, 0.0021 
mmol, Mn = 14,300) was dissolved in 4 mL of HBS, pH 7.2 and purged with nitrogen for 10 
min.  TCEP·HCl (6.0 mg, 0.021 mmol; in 1 mL HBS) was added, and the reaction was stirred 
151 
 
for 1 h at room temperature under nitrogen.  N-ethyl maleimide (5.3 mg, 0.042 mmol; in 1 mL 
HBS) was transferred, and the reaction was allowed to stir overnight at room temperature.  The 
product was purified by dialysis using Spectra/Por regenerated cellulose dialysis tubing (3.5 
kDa MWCO) against deionized-water for 3 days and lyophilized for 24 h.                 
AI.2.5 Characterization.  Mn and PDI for polymers were obtained using a Waters Gel 
Permeation Chromatography (GPC) system equipped with two UltrahydrogelTM columns 
(Waters) in series (500 Å and 250 Å), a 1515 isocratic HPLC pump and a 2414 refractive index 
detector.  Temperature throughout the system was controlled at 30 °C.  The mobile phase 
employed was phosphate buffer saline (pH=7.4) at a rate of 0.8 mL min-1 calibrated with 
poly(methacrylic acid), sodium salt standards.  1H NMR was performed using a Inova 400MHz 
spectrometer with deuterium oxide (D2O) as the solvent. 
 
AI.3 Results and discussion 
pAA was synthesized via RAFT polymerization using A-CPA as the radical initiator and 
CPA-DB as the chain transfer agent (Figure AI.1).  Figure AI.2(A-B) shows the H1 NMR (400 
MHz, D2O) spectra of pAA synthesized by RAFT polymerization in (A) methanol and (B) 
water/1,4-dioxane (4:1 v/v).  The chemical shifts for the protons in the pAA backbone are 
distinguished at 1.2-2.0 ppm (methylene, -CH2) and 2.0-2.8 ppm (methyne, -CH).  For pAA 
synthesis in methanol (Figure AI.2A), the H1 NMR spectra revealed a peak at 3.7 ppm 
corresponding to the protons in the pendant methyl group (-CH3) produced from the 
esterification of side chain carboxyl groups with methanol.  The degree of methylation 
corresponds to approximately 6% of the total initial available carboxyl groups in pAA.  For 
comparison,   an  analogous  polymerization  was  conducted   in  water/1,4-dioxane   (4:1 v/v).   
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Figure AI.1: Synthesis schematic of pAA by RAFT polymerization in methanol 
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Figure AI.2: 1H NMR spectra (400MHz, D2O) of pAA synthesized by RAFT polymerization in 
(A) methanol; (B) water/1,4-dioxane (4:1 v/v); (C) methanol followed by NaOH treatment. 
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Polymerizations conducted in water/1,4-dioxane (Figure AI.2B) did not produce any side chain 
modification.  Interestingly,  partial  methylation  is  not  observed  in  methacrylic acid     
RAFT polymerization under equivalent conditions8. 
 Under alkaline conditions, esters undergo hydrolysis by the nucleophilic attack of 
hydroxides.  Poly(acrylic acid)-co-poly(methyl acrylate) (pAA-co-pMA) (Structure i in Figure 
AI.1) successfully undergoes hydrolysis of the ester bonds in the methyl acrylate units by 
treatment with 3N sodium hydroxide (NaOH) or higher NaOH concentrations.  The final 
product is the sodium salt of pAA (Structure ii in Figure AI.1), as confirmed by the complete 
elimination of the -CH3 peak at 3.7 ppm in the 1H NMR spectrum (Figure AI.2C).  Treatment of 
pAA-co-pMA with lower NaOH concentration hydrolyzes only a percentage of the esters.  
Strong protic acids, such as hydrochloric acid (HCl) or trifluoroacetic acid (TFA) can also 
promote ester hydrolysis.  However, treatment of pAA-co-pMA with either 1 N HCl or 
TFA/water = 4:1 (v/v) had minimal effect on ester hydrolysis of the MA units.  For our 
purposes, treatment with 3N NaOH was an effective route to achieve pAA; however, strong 
basic environments can also lead to hydrolysis of the thiocarbonylthio end-groups that result 
from the RAFT CTA.  
 In some circumstances where the RAFT CTA end-group functionality is not desired, 
hydroxides, as well as other reagents including borohydrides and amines, are used to cleave the 
thiocarbonylthio end-group3,4,9,10.  This post-polymerization modification generates a thiol end-
group (-SH).  Strong oxidizing environments, as well as the presence of oxygen, can promote 
coupling of thiol groups to form disulfide bonds between polymer chains.  As seen in the GPC 
trace in Figure AI.3A, a bimodal molecular weight distribution was obtained after 3N, 5N and 
10N NaOH treatments corresponding to a two-fold increase in the peak-average molecular 
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weight (Mp).  Molecular weight distribution (i) corresponds to a pAA of Mp = 17,800, Mn = 
14,300 and PDI = 1.23.  After NaOH treatment, the molecular weight distributions (ii)-(v) show 
a second peak of Mp = 34,500, close to two-fold the Mp of peak (i).  The overall Mn and PDI 
increased to 18,600 and 1.31, respectively.  As the NaOH concentration increases, the higher Mp 
peak becomes smaller relative to the lower Mp peak.  It was previously shown that excess 10N 
NaOH to neutralize pAA post-polymerization (with trithiocarbonates as CTA), produces a 
substantial reduction in the sulfur content by the polymer end-group, as determined from 
elemental analysis4.  This phenomenon was considered a result of decomposition of the thiol 
group in base.  Therefore, using excess of 10N NaOH may be a potential route to avoid bridging 
between polymer chains if having a thiol end-group is not needed for further post-
polymerization modifications.  
 Alternatively, disulfide bonds can be cleaved by reducing agents such as TCEP.  As seen 
in Figure AI.3B, after treatment with TCEP/N-ethyl maleimide, the molecular weight 
distribution corresponding to the higher Mp was diminished, and only one molecular weight 
distribution peak was observed corresponding to the lower Mp pAA (vi).   
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Figure AI.3: Molecular weight distribution for AA RAFT polymerization conducted in 
methanol.  A(i) no NaOH treatment; A(ii) 3N NaOH, NaOH:methanol (v/v) = 2:1; A(iii) 5N 
NaOH, NaOH:methanol (v/v) = 2:1 A(iv); 10N NaOH, NaOH:methanol (v/v) = 2:1; A(v) 10N 
NaOH, NaOH:methanol (v/v) = 5:1; B(ii) 3N NaOH, NaOH:methanol (v/v) = 2:1; and B(vi) 
TCEP/maleimide treatment. 
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APPENDIX II 
SYNTHESIS AND CHARACTERIZATION OF PEGYLATED POLYMER 
CONJUGATES 
 
AII.1 Introduction 
 Incorporating polyethylene glycol (PEG) into polymer vectors is an alternative method to 
enhance polyplex stability in the presence of serum proteins.  Copolymer of polymer conjugates 
and PEG were synthesized for a selected number of polymers, specifically 5-P2, 5-P3, 10-P2 and 
10-P3.  These polymers were selected for the evaluation of in vivo siRNA delivery to the liver 
(Appendix III). 
 
AII.2 Materials and methods 
AII.2.1 Materials.  Tris(2-carboxyethyl) phosphine hydrochloride (TCEP·HCl) was purchased 
from Fisher Scientific.  Methoxypolyethylene glycol 5,000 maleimide (PEG-mal) was purchased 
from Fluka.  HEPES buffer saline (HBS, 10 mM HEPES, 150 mM NaCl, pH 7.2) was prepared 
with ultrapure water and filtered through a 0.2 µm PES membrane.   
AII.2.2. Synthesis of PEG-co-pAA conjugates.  A representative example for PEG 
conjugation to polymer conjugates end-group in 5kDapAA-78%Agm-3%Gal (5-P2) is as 
follows: In a 25 mL pear-shaped flask equipped with a magnetic stir bar, 5-P2 (30 mg, 0.0029 
mmol) was dissolved with 13 mL of HBS, pH 7.2 and purged with nitrogen for 10 min.  
TCEP·HCl (4.2 mg, 0.015 mmol in 1 mL HBS) was transferred, and the reaction was stirred for 
1 h at room temperature under nitrogen.  PEG-mal (29 mg, 0.0058 mmol in 1 mL HBS) was 
transferred and the reaction was allowed to stir overnight at room temperature under nitrogen.  
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The product was purified by 8 times centrifugal filtration using Millipore Amicon Ultra filter 
units (regenerated cellulose, 10kDa MWCO), filtrated through a 0.2 µm PES membrane (sterile 
Acrodisc filter, Pall Corporation) and lyophilized for 24 h.     
AII.2.2 Biophysical and cellular characterization.  Biophysical and cellular characterization of 
PEGylated polymer conjugates were performed as previously described in Chapter 4. These 
include binding affinity of polymers with siRNA, polyplex effective diameter, polyplex zeta 
potential and cytotoxicity. 
 
AII.3 Results and discussion 
 The conjugation of PEG into the polymer conjugates was mediated via a maleimide-
thiol coupling reaction as shown in Figure AII.1.  PEGylated polymer conjugates showed 
binding affinities to siRNA similar to non-PEGylated polymer conjugates (Chapter 4).  P2 
polymers are able to condense ~80% of the siRNA at a polymer:siRNA (w:w) > 5:1, while P3 
polymers are able to condense ~60% - 70% of the siRNA at a polymer:siRNA (w:w) > 10:1 
(Figure AII.1).  At polymer:siRNA (w:w) corresponding to their non-PEGylated counterparts 
both effective diameters and zeta potentials were reduced, particularly for 10-P2-PEG and 10-
P3-PEG polymers (Table AII.1).  Moreover, the cytotoxicity of these polymers on MDA-MB-
231-luc+ cells was significantly reduced by the incorporation of PEG chains into the polymer 
conjugates.  IC50 values for PEGylated polymer conjugates were close to two-fold higher than 
for their non-PEGylated counterparts (Table AII.2).       
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Figure AII.1: Synthesis schematic for PEGylation of polymer conjugates. 
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Figure AII.2: Relative binding affinity of polymer conjugates with siRNA as measured by 
ethidium bromide fluorescence quenching.  N=3.  Error bars represents standard deviation.  
25kDa PEIb was included for comparison. (A) 5kDa-P-PEG; (B) 10kDa-P-PEG.   
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Table AII.1: Biophysical characteristics (size and zeta potential) of PEGylated polymer 
conjugates.a 
Entry Polymer w:w ratio Effective diamter (nm) Zeta potential (mV) 
1 5-P2-PEG 15:1b 94.1 + 6.6 14.6 + 1.1 
2 5-P3-PEG 30:1c 105.2 + 30.4 11.1 + 0.8 
3 10-P2-PEG 12:1d 39.9 + 19.9 16.4 + 1.5 
4 10-P3-PEG 25:1e 38.3 + 14.1 16.2 + 1.3 
 
aEffective diameter and zeta potential of polyplexes as determined by dynamic light scattering (DLS) using a 
Malvern Zetasizer Nano-ZS.  bw:w = 15:1 (5-P2-PEG) corresponds to w:w = 10:1 of 5-P2.  cw:w = 30:1 (5-P3-PEG) 
corresponds to w:w = 20:1 of 5-P3.  dw:w = 12:1 (10-P2-PEG) corresponds to w:w = 10:1 of 10-P2.  ew:w = 25:1 
(10-P3-PEG) corresponds to w:w = 20:1 of 10-P3.             
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Table AII.2: IC50 values for PEGylated polymer conjugates after 48 h incubation with MDA-
MB-231-luc+ cells (MTS assay).  N=3.  
Entry Polymer IC50, free polymer 
1 5-P2-PEG 12.7 + 0.3 
2 5-P3-PEG 97.6 + 1.2 
3 10-P2-PEG 16.6 + 1.2 
4 10-P3-PEG 27.4 + 1.9 
 
 
 
 
 
 
165 
 
APPENDIX III 
PRELIMINARY DATA ON IN VIVO siRNA DELIVERY 
 
 All animal experiments were performed according to federal and state regulations, and 
approved by the Institutional Animal Care and Use Committee (IACUC) at Cornell University.  
For transfection experiments, female 8-week old (~20 g) Balb/c mice (Charles Rivers 
Laboratory) were intravenously injected via the tail vein with a single dose (200 µL) of 
siRNA/polymer complex, Invivofectamine 2.0 reagent (Invitrogen), naked siRNA or buffer.  
Polyplexes were formed at the designated polymer:siRNA (w:w) ratio in 10mM HEPES buffer, 
5% glucose, pH 7.2 with [siRNA] = 2.5 mg/kg body weight.  Complexes from Invivofectamine 
2.0 reagent were formed according to the manufacturer's instruction in PBS with [siRNA] = 2.5 
mg/kg body weight.  At designated times post-transfection (48 h and 96 h), blood was collected 
via submandibular bleed.  Factor VII protein levels in serum were determined using a Biophen 
FVII assay (Aniara Corporation) according to the manufacturer's instructions.   
 All conditions analyzed are shown in Table AIII.1.  Preliminary data for in vivo siRNA 
delivery revealed that 5-P3, 10-P3 and 10-P3-PEG were well tolerated by mice at the specified 
conditions.  However, no significant Factor VII protein knockdown was achieved as compared to 
Invivofectamine 2.0 reagent, the positive control, which achieved > 95% protein knockdown 
(Figure AIII.1).  Perhaps the conditions analyzed were not optimal or tissues other than the liver 
were targeted by these polymeric vectors.  In the case of 5-P2, 5-P2-PEG, 5P3-PEG, 10-P2 and 
10-P2-PEG, toxicity was generated as perceived by weight loss or death of mice.  Further 
analyses are needed to fully evaluate the efficacy of these polymeric vectors for siRNA delivery 
in vivo.  
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Table AIII.1: Polymer conjugates analyzed for in vivo siRNA delivery.a 
Entry Polymer w:w ratio 
1 5-P2 5kDapAA-76%A-2%G 15:1 
2 5-P2-PEG PEG-co-5kDapAA-76%A-2%G 22.5:1b 
3 5-P3 5kDapAA-55%A-17%G 20:1 
4 5-P3-PEG PEG-co-5kDapAA-55%A-17%G 30:1c 
5 10-P2 10kDapAA-78%A-3%G 15:1 
6 10-P2-PEG PEG-co-10kDapAA-78%A-3%G 18.8:1d 
7 10-P3 10kDapAA-56%A-18%G 20:1 
8 10-P3-PEG PEG-co-10kDapAA-56%A-18%G 25:1e 
 
aPolyplexes were intravenously injected into mice through the tail vein at the designated polymer:siRNA (w:w) ratio 
in 200 µL of 10mM HEPES buffer, 5% glucose, pH 7.2 with [siRNA] = 2.5 mg/kg body weight.  bw:w = 22.5:1 (5-
P2-PEG) corresponds to w:w = 15:1 of 5-P2.  cw:w = 30:1 (5-P3-PEG) corresponds to w:w = 20:1 of 5-P3.  dw:w = 
18.8:1 (10-P2-PEG) corresponds to w:w = 15:1 of 10-P2.  ew:w = 25:1 (10-P3-PEG) corresponds to w:w = 20:1 of 
10-P3.             
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Figure AIII.1: (A) Relative FVII protein expression (%) 48 h and 96 h post-transfection.  (B) 
Weight gains (%) 48 h and 96 h post-transfection.  Conditions evaluated: 5-P3 (w:w = 20:1), 10-
P3 (w:w = 20:1), 10-P3-PEG (w:w = 25:1), Invivofectamine 2.0 reagent (IF), naked siRNA and 
buffer (10mM HEPES, 5% glucose, pH 7.2). [siRNA] = 2.5 mg/kg body weight; total injection 
volume = 0.01 mL/g body weight.  N = 4 for all conditions except IF (N = 3).  Error bars 
represent standard deviation.  
 
